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Abstract
Membrane proteins are proteins either embedded or located at the peripheral of the biological membrane.
The functions of membrane proteins include importing/exporting ions/small molecules into/output of the
cell, cellular signaling, cell-cell interactions, etc. Molecular dynamics is a powerful computational tool that
can provide an atomic level description of the dynamic interactions between molecules. During my Ph.D., I
have studied several membrane proteins, including a membrane transporter (BetP), three ligand-gated ion
channels (AMPA receptor, Glycine receptor, and GLIC), and a membrane signaling protein (human T-cell
receptor). In these projects, I have uncovered key aspects of the functional mechanism of these proteins, such
as active substrate transport, ion permeation, and antigen recognition. In addition, I have developed a new
computational methodology for modeling the membrane protein-detergent micelles. I strongly believe that
an atomic-level understanding of membrane proteins is essential to meet the challenges in biomedicine.
ii
To my parents and grandparents
iii
Acknowledgments
To my advisor Prof. Emad Tajkhorshid, thank you for your exceptional ability of mentoring. To the
professors and staff of the Biophysics program, especially Cindy Dodds, thank you for making my Ph.D.
study such a great experience. To my collaborators inside and outside the University of Illinois, thank you
for giving me the opportunities and knowledge on conducting cutting-edge scientific research. To my friends
within and outside the Tajkhorshid lab, thank you all for your help and support during my Ph.D.
iv
Table of Contents
Chapter 1 Biological Membranes and Membrane Proteins . . . . . . . . . . . . . . . . . . 1
Chapter 2 Changing the Peptide Specificity of a Human T-cell Receptor . . . . . . . . . 6
Chapter 3 Activation Mechanism of the AMPA Receptor . . . . . . . . . . . . . . . . . . 23
Chapter 4 The Open-State Structure of Pentameric Ligand-Gated Ion Channels . . . . 33
Chapter 5 Proton-Coupled Substrate Transport in the BetP Membrane Transporter . . 53
Chapter 6 SimShape: a Method for Proteomicelle Modeling . . . . . . . . . . . . . . . . . 71
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100
v
Chapter 1
Biological Membranes and Membrane
Proteins
Cell, according to the “cell doctrine” (1), is the basic unit of all life forms (except for viruses). The most
import and distinct feature of the cell is the the cellular and compartment membrane envelopes which provide
the insulation for different biochemical reactions to occur in parallel. The foundation of cell membrane is
a two-dimensional (2D) layer formed by lipids and cholesterols, which are amphipathic molecules that can
self-assemble into bilayers with a hydrophobic interior and two hydrophilic surfaces (2). This bilayer acts as
a barrier to prevent the permeation of ions, water, and other hydrophilic molecules. On the other hand, each
cell is an open system, which requires exchanging molecules with its environment to maintain metabolism.
Furthermore, membrane surface sensors are required for the transduction of external stimuli to intracellular
signal cascades. All these requirements are fulfilled by membrane proteins.
Membrane proteins are highly efficient nanoscale machines for various biological functions, such as bio-
chemical reaction catalysis, cellular recognition, singling, and import and export of molecules into and out
of the cell. Understanding membrane proteins at the atomic level is essential for predicting their behav-
iors and designing biomedical applications targeting these proteins. Experimental approaches such as IR
spectroscopy, Nuclear Magnetic Resonance (NMR), X-ray crystallography, and cryo-electron microscopy
(cryo-EM) are often limited in resolution or limited in the ability to characterize the protein dynamics.
Computational techniques, such as Molecular Dynamics (MD) and its related methods, are effective tools
for providing an atomic-level description of the membrane protein dynamics and functions. My Ph.D.
research involves applying computational techniques to the study of a wide range of integral membrane pro-
teins namely membrane receptors (e.g. the T-Cell antigen receptor and the AMPA receptor) and membrane
transporters (e.g., the BetP transporter) (Fig. 1.1). The ultimate goal of these studies is to provide insight
into the functional mechanism of each class of membrane proteins. In addition, I have also developed a novel
method for constructing protein-detergent micelles (proteomicelles) for studying the effects of detergents on
membrane protein stability.
Membrane receptors are proteins embedded in the cell membrane for mediating the sensing of signaling
molecules, light, temperature, pressure, etc. (2). During my Ph.D., I have worked on two types of membrane
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FIGURE 1.1 Different types of membrane proteins
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receptors: metabotropic and ionotropic receptors. Metabotropic receptors triggers either the release of
signaling molecules or biochemical reactions (e.g. phosphorylation/dephosphorylation), while ionotropic
receptors are ligand-gated ion channels. One type of metabotropic receptors is the T-cell antigen receptor
(TCR) which I have studied in collaboration with the research group of Prof. David Kranz (Biochemistry,
UIUC). A TCR has two components: the alpha and beta chains. Each of which has three complementary
determining regions (CDRs) that determine TCR’s binding affinity to the major histocompatibility complex
(MHC) and the antigen peptide bound to MHC. A remarkable aspect of TCR is that just by changing
the residue identities at the CDR regions, the antigen specificity of a TCR can be completely shifted.
In this study, the TCR has be engineered to shift its binding specificity from its cognate peptide to a
cancer-associated peptide MART1 (3). To understand how mutations in the CDR regions alter the antigen
specificity, I, together with my colleague Javier Baylon, performed MD and Steered MD (SMD) simulations to
investigate changes in the atomic interactions between an engineered TCR and an MHC bound to an antigen.
We have found that new salt bridge interactions are introduced due to the mutations in the CDR regions.
More interestingly, insertion of a highly hydrophobic residue (tryptophan) into the antigen-MHC interface
has been found to increase binding affinity. These computational results provide a physical understanding
of the effect of mutations on TCR’s affinity to different antigens as well as a foundation for rational design
of TCR for cancer therapy. This work has been published in the journal Nature Communications in 2014
(3).
Ionotropic receptors are usually composed of a ligand binding domain and a transmembrane channel
domain with pore-like structures that facilitate the passive conduction of ions and other substrates across the
membrane. Depending on the activation mechanism, ionotropic receptors can be classified into voltage-gated
ion channels, ligand-gated ion channels, and ion channels gated by other signals (e.g., mechanosensitive ion
channels). One type of the ligand-gated ion channels I studied is the GluA2 AMPA receptor, in collaboration
with the research group of Prof. Eric Gouaux (Vollum Institute). AMPA receptors are essential for the
excitatory neurotransmission in the central nervous systems of humans and other mammals (4). There are
three physiological states in membrane channel proteins: closed, active, and desensitized states. Before
this project, only the closed and desensitized states of the AMPA receptor were structurally known (5, 6).
Obtaining the structural information of the active and desensitized states is crucial for our understanding of
the molecular basis of human neurological functions. On the experimental side, cryo-EM was used to obtain a
low-resolution electron density map for GluA2 at its activate state, stabilized by its natural auxiliary protein
TARP γ2. I applied a cryo-EM structure refinement methodology named Molecular Dynamics Flexible
Fitting (MDFF) (7, 8) to further refine the active structure staring from a structure based on homology
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modeling. In addition, I, together with my colleague Mrinal Shekhar, performed a series of MD and SMD
simulations to investigate the mechanism and pathway of the ion permeation and the two-fold symmetric
solvation patterns in the transmembrane channel region of the activated GluA2. The results have been
published in the journal Cell in 2017 (4).
Another type of ionotropic receptor is the pentameric ligand-gated ion channel (pLGIC). This family of
channel proteins features a pentameric transmembrane domain which forms the ion-conduction pore and an
extracellular domain for binding to ligands. Over the past few years, many crystal and cryo-EM structures
have been determined for the members of pLGICs. However, no consensus has been reached on the atomic
level description of the active state of pLGICs. Through a recent collaboration with the research group of
Prof. Claudio Grosman (physiology, UIUC), I studied two members of pLGIC: GLIC and glycine receptor
(GlyR). In this project, the GLIC channel protein has been studied with open-channel stabilizing mutations.
This variant of GLIC has a markedly prolonged open-channel lifetime. Therefore, it can provide valuable
information on the active state. The structure of this GLIC variant has been determined using X-ray
crystallography and its channel kinetics quantified by electrophysiology. I applied MD and SMD simulations
to study both the open and closed states of GLIC. In addition, I also studied two open-state variants of
GlyR, with and without inhibitory channel toxins bound to the transmembrane channel region. We have
identified the structural features corresponding to the pLGIC proteins at their active states. This project
also has bridged the gap between physiological studies at the non-equilibrium state and the structural studies
at the equilibrium state. I have also developed a new computational method for quantifying the effect of
ion-channel size on ion permeability. The results have been accepted for publication in the Journal of General
Physiology (9).
Membrane transporters are proteins that facilitate active (energy-dependent) substrate transport across
the membrane through large-scale conformational transitions. One distinct feature of membrane transporters
compared to membrane channels is that transporters do not simultaneously open to the extracellular and
intracellular sides. One type of transporter I have worked with is BetP, which regulates osmotic pressure in
bacterial cells. BetP has LeuT-fold protein structure and its conformational transition follows the alternating
access model (Fig. 1.2). I have employed microsecond scale molecular dynamics simulations as well as free
energy calculations to study the effect substrate binding/release on the conformational transition. My results
provide evidence that substrate release can trigger global conformational transitions from the inward-facing
state to the occluded state. These results also suggested the protonation state of the substrate binding site
residue is critical for the substrate release event.
Detergents are widely used in membrane protein research, from membrane protein extraction and pu-
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FIGURE 1.2 The alternating-access model for membrane transporters.
rification to structure determination. Different detergent species and concentration can have strong effects
on the stability of the target proteins. Many experimental and computational projects have been devoted
to the characterizations of the detergent effect. MD simulations provide an effective tool for studying these
effects at the atomic level. An initial proteomicelle model is essential for studying the effect of different
micelle aggregation number on protein stability. Currently there are very few existing methodologies for
building proteomicelle models. Many of these methods are very limited in terms of modeling proteomicelles
of different micelle aggregation numbers and suitability for membrane proteins of different sizes and shapes.
I have designed and implemented a new method named SimShape (”Simulated Shape”) to overcome these
limitations. The idea of SimShape is to use accelerated molecular dynamics to simulate the proteomicelle
formation. The key component of the acceleration is the application of an external attractive force to arrange
detergents around the target protein at predefined regions. SimShape depends on a customized grid poten-








Heterodimeric αβ T-cell receptors (TCRs) are responsible for recognizing antigenic peptides presented in the
context of a product of the major histocompatibility complex (MHC) on the surface of antigen-presenting
cells. The interaction of a TCR and a peptide/MHC (pepMHC) can drive the T cell into various states of
activation, depending on the affinity (or dissociation rate) of binding. This recognition also operates during
thymic development of a T cell in a process that selects for T cells with TCRs that bind with low affinity
to self-pepMHC complexes (positive selection), but deletes T cells with TCRs that bind too strongly to
self-pepMHC complexes (negative selection or tolerance) (10, 11). T cells exported to the periphery are thus
positioned to discriminate between a normal, healthy cell and one that expresses aberrant pepMHC due to
an infectious agent such as a virus or due to cell transformation to a cancerous state.
TCRs contain six complementarity determining regions (CDRs), three (CDR1, CDR2 and CDR3) in each
α-chain and β-chain, which are involved in binding pepMHC ligands. Based on the solved TCR:pepMHC
structures (12, 13), a common diagonal docking orientation positions the TCR such that the CDR1 and
CDR2 loops encoded by the germline variable (V) region genes are typically positioned over the helices of the
MHC. The CDR3 loops of each chain are encoded by nucleotides at the junctions of somatically rearranged
gene segments, and these hypervariable regions are appropriately positioned over the peptide (12, 13).
Although it was originally thought that peptide specificity was determined in large part through interactions
of CDR3 loops with the peptide, many studies have suggested that antigen specificity is more complex. For
example, in an early study of I-Ek-restricted TCRs that recognized distinct peptides, transplantation of
CDR3 loops was not sufficient to confer peptide reactivity, even when the same Vα chains were used by the
two TCRs (14). Based on current thinking, specificity in the TCR:pepMHC interaction can occur through
various mechanisms, including the following: 1. residues in the germline-encoded CDR1 loops that make
direct contact with peptide (15–18). 2. CDR1 and CDR2 contacts with MHC that yield peptide-specific
1 Reproduced in part with permission from the journal Nature Communications. S. Smith, Y. Wang, J. Baylon, N. Singh,
B. Baker, E. Tajkhorshid and D. Kranz. Nat. Commun., 5:5223 (2014)
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interactions indirectly by altering MHC contact with the peptide (13, 19). 3. CDR3 loops that modulate
contacts between CDR1/CDR2 residues and MHC (20–23). 4. peptide influences that have an impact on
MHC interactions with CDR1, CDR2, or even CDR3 residues (24–26).
Given the complexity of interloop interactions among CDRs, it is difficult to use computational ap-
proaches to predict the basis of peptide specificity by TCRs, let alone to design TCRs with novel specificities
de novo. Directed evolution has been used to engineer TCRs with large improvements in binding affinity (or
altered fine specificity (27)), while maintaining antigen specificity (28–34). These studies have frequently
targeted CDR3 regions for mutagenesis to accomplish affinity maturation, but mutations in CDR1 and
CDR2 loops have also yielded improvements in affinity while maintaining peptide specificity (30–32, 34, 35).
Furthermore, computational approaches have been used to guide improvements in TCR affinity, with only
subtle effects on specificity (36–39).
Although affinity maturation of TCRs has been achieved, there have not been reports in which the
specificity of a TCR has been changed to a completely different peptide using directed evolution (that is,
from the cognate peptide to a non-cognate peptide). Here we describe the successful in vitro engineering
of the human TCR A6 that recognizes a cognate nonameric peptide from the viral protein Tax, converting
the TCR to one that specifically recognizes a non-cognate decameric peptide from the melanoma antigen
MART1. The study shows that it is possible to use directed evolution and in vitro approaches to engineer
TCRs with alternative specificities, opening the possibility for rapid discovery of TCRs against a large array
of cancer, viral and autoimmune antigens.
Methods
System preparation
Four combinations of two engineered TCR (A6 and RD1-MART1) and two antigens (Tax/HLA-A2 and
MART1/HLA-A2) were built and simulated: A6:Tax/HLA-A2, A6:MART1/HLA-A2, RD1-MART1:Tax/HLA-
A2 and RD1-MART1:MART1/HLA-A2. Crystal structure of the high-affinity TCR mutant A6-c134 (PDB
ID: 4FTV) (40) was used as the template for all four systems. Note that the structure of RD1-MART1:
MART1/HLA-A2 wasn’t available at the time of this project (2014) and was only resolved recently (41).
For system A6:Tax/HLA-A2 and RD1-MART1:Tax/HLA-A2, crystal structure of A6-c134:Tax/HLA-A2 was
used to build the initial system. The RD1-MART1 TCR structured was created by mutating residues of A6-
c134 TCR. The initial structures of peptide Tax was taken from the crystal structure of A6-c134:Tax/HLA-
A2 (PDB ID: 4FTV) (40) and the structure of peptide MART1 was taken from the crystal structure of
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DMF5:MART1/HLA-A2 (PDB ID: 3QDG) (15). An alternative way of building A6-c134 TCR was also
tested by mutating wild type A6 TCR structure (17) residues at positions 99-102 (CDR3β loop) from
AGGR to MSAQ. Due to the similarity in TCR orientation compared to crystal 4FTV (40), this system is
also considered to start from the 4FTV/A6-c134 orientation.
Both TCR and MHC were truncated to simplify the system for better sampling of the conformational
dynamics. Only the following residues were kept: residues 1-182 in MHC, residues 1-119 in TCR α-chain and
residues 30-122 in TCR β-chain. In all simulations, the Cα atoms of residues 30, 32, 96, 122 and 182 in MHC
were restrained (k = 1 kcal/mol/Å2). In the simulations with 4FTV/A6-c134 orientation (A6:Tax/HLA-
A2, A6:MART1/HLA-A2, RD1-MART1:Tax/HLA-A2, and RD1-MART1:MART1/HLA-A2), the following
atoms were also restrained (k = 1 kcal/mol/Å2) to preserve the binding orientation: backbone carbonyl
carbon atoms of residue 119 in TCR α-chain and residue 122 in TCR β-chain.
Due to the unavailability of the RD1-MART1:MART1/HLA-A6 complex at the time of this project,
the exact binding orientation of RD1-MART1 TCR relative to MHC was unknown. Based on the available
crystal structures of MART1/HLA-A2 with other types of TCR’s, three other orientations were tested, which
are referred to as 3QDG/DMF5 (15), 3QDM/DMF4 (15), 3HG1/Mel5 (16), respectively.
In addition to the above systems, to verify the applicability of molecular dynamics (MD) to the TCR/MHC
system, two test systems were also prepared. One was based on the wild type A6:Tax/HLA-A2 (PDB ID:
1AO7) and the other based on DMF5:MART1/HLA-A2 (PDB ID: 3QDG). Both the TCR and MHC were
truncated. For A6:Tax/HLA-A2 system, only the following residues were kept: residues 2-120 in TCRα,
residues 3-122 in TCRβ, and residues 1-182 in MHC. For DFM5:MART1/HLA-A2 system, only the following
residues were kept: residues 1-108 in TCRα, residues 4-116 in TCRβ, and residues 1-182 in MHC. In the
crystal structure 3QDG, residue F100β is deeply buried. To test whether MD can predict the side chain
orientation of this residue, the χ1 side chain dihedral of F100β was rotated by 180◦ and the χ2 dihedral was
rotated by 90◦.
Molecular dynamics
Each of the four systems with 4FTV/A6-c134 orientation was first energy-minimized for 1000 steps and
then simulated under constant volume/temperature (NVT) condition for 500 ps, with all backbone atoms
restrained (k = 10 kcal/mol/Å2). This was followed by a 4 ns relaxation simulation under constant pres-
sure/temperature (NPT) condition with restrains on backbone atoms gradually removed. Then systems with
A6 TCR were simulated for 100 ns each except for the test system with wild type A6 TCR conformation
(40 ns). Systems with RD1-MART1 TCR were simulated for 170 ns each.
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Orientation quaternion based targeted molecular dynamics (TMD) was used to gradually modify the bind-
ing conformation towards new orientations defined by structures of crystals 3QDG (15), 3QDM (15), and
3HG1 (16). The collective variable (reaction coordinate) was defined by the orientation quaternion (42) of
TCR. A 40-ns TMD simulations were performed to obtain the 3QDG/DMF5, 3QDM/DMF4 and 3HG1/Mel5
binding orientation with force constant 50,000 kcal/mol/radian2 for 3QDM/DMF4 and 3HG1/Mel5 orienta-
tions, and 100,000 kcal/mol/radian2 for 3QDG/DMF5 orientations. Each system was relaxed for 60 ns. To
accelerate the conformational sampling and allow TCR to form new interactions with MHC, non-bonded in-
teractions were decreased from 1.0 to 0.8 and then reverted back to 1.0 with a step size of 0.05 and simulated
for 4.8 ns/step. The A6:MART1/HLA-A2 in 3QDG/DMF5 orientation was further simulated for 100 ns,
but only 50 ns for the 3HG1/Mel5 and 3QDM/DMF4 orientations since no significant binding interactions
were observed. The RD1-MART1:MART1/HLA-A2 complex was further simulated for 170 ns each for all
three new orientations.
For the simulation DMF5:MART1/HLA-A2 complex, the backbone of TCR and all heavy atoms in
MART1/HLA-A2 were restrained (k = 1 kcal/mol/Å2) during the simulation. The system was first energy-
minimized for 1000 steps and simulated for 4.3 ns under constant temperature and volume (NVT) condition.
CHARMM27 force field (43) was used for protein, water and ions. Bonds involving hydrogen atoms were
constrained by SETTLE algorithm (44). Periodic boundary conditions were applied and the time step was
2 fs. The cutoff distance for nonbonded interactions was 12 Å and the switching function took effect at 10
Å. Particle mesh Ewald method (45–47) was used for calculating long-range electrostatic interactions. The
average temperature was maintained at 310 K using the Langevin dynamics (48) with a damping coefficient
of 1/ps. The average pressure was maintained at 101.325 kPa using isotropic Nosé-Hoover-Langevin method
(49, 50) with an oscillation period of 200 fs and a damping time scale of 50 fs. Energy minimization was
performed using conjugated gradient (51) in combination with the line search algorithm (52).
Analyses
Solvent accessible surface area
To quantify the extent to which a residue is excluded from the bulk solvent, solvent accessible surface area
(SASA) was calculated for the heavy atoms of residues W101α, W98β (for RD1-MART1), or L99β (for A6-
A134) with the backbone heavy atoms of Tax or MART1 peptides and MHC as the environment. All SASA
data were normalized by the SASA values of the same residues alone in vacuum. The initial equilibration




The residue-residue interactions were quantified by the minimum distances between the side chain terminal
atoms from the pair of residues, e.g., the side chain nitrogen atom in arginine and the carboxyl oxygen atoms
in glutamate. Histogram analysis was applied to the measured minimum side chain interaction distances
from the trajectories (excluding the first 3 ns). The maximum likelihood distance was used the representative
interaction distance.
Results
Molecular mechanism of peptide specificity switching in RD1-MART1
To gain insight into the underlying molecular mechanism of peptide specificity, comparative molecular dy-
namics (MD) simulations were performed on two complexes, A6:Tax/HLA-A2 and RD1-MART1:MART1/HLA-
A2. To determine whether MD was a valid method to analyze possible mechanisms of specificity of the RD1
variants, two sets of validation simulations were performed. First, we showed that MD simulations would
correctly predict the backbone and side-chain orientations of the CDR3β loop of high-affinity TCR A6-c134
derived from A6 (see Methods and Fig. 2.3, 2.4). Second, we determined that MD simulations could accu-
rately predict the insertion of the side chain of residue F100β in the DMF5 TCR (PDB: 3QDG)(15) (see
Methods and Fig. 2.5).
For MD simulations of RD1-MART1:MART1/HLA-A2, four different initial models were constructed
based on the A6-c134:Tax/HLA-A2 orientation (PDB: 4FTV) as well as three different orientations ob-
served for decameric MART1/HLA-A2 in complex with different MART1-specific TCRs (DMF5, DMF4
and Mel5; PDBs: 3QDG, 3QDM and 3HG1, respectively) (15, 16, 40) (see Methods for details). Two dis-
tinct peptide–TCR interaction patterns were observed for A6 and RD1-MART1, which could account for
their differential peptide-binding specificity and affinity. Key interactions in the A6:Tax/HLA-A2 complex
identified by screening for hydrogen bonding and electrostatic interactions included three hydrogen bonds,
namely, Y5Tax-R95β, Y5Tax-S31α and Y8Tax-E30β (Fig. 2.1a and 2.6). A recent mutational study suggested
that A6 interactions with Y8Tax provided significant binding energy (25). Consistent with this, the L98β
mutations in the present study probably influenced a van der Waals interaction between Y8Tax and L98β.
Our simulations also identified a key hydrogen bond between Y8Tax and E30β.
The MD simulations also identified A6-c134:HLA-A2 interactions involving a salt bridge between D99α
and R65MHC of HLA-A2. In addition, a salt bridge between D99α and K66MHC of HLA-A2 occasionally
formed during the simulations, with the orientation of the D99α side chain being further stabilized by the
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FIGURE 2.1 (a) Specific hydrogen bonding and salt-bridge interactions are shown for A6-c134:Tax/HLA-A2. (b) A
superposition of A6-c134:Tax/HLA-A2 and RD1-MART1:MART1/HLA-A2 (3QDG/DMF5-orientation), highlighting
the extra space created by the curvature of MART1 but not by Tax.
hydroxyl group of T98α (Fig. 2.6). These contacts probably play a role in further enhancing TCR:HLA-
A2 interactions (Fig. 2.6). The importance of T98α and D99α in A6 TCR recognition has recently been
established by mutational analysis (25). Interestingly, the selection of T98α and D99α by Tax/HLA-A2,
but not by MART1/HLA-A2 (where K98α and Y99α were selected), also indicates that the peptide has a
strong influence on these TCR:HLA-A2 interactions.
In contrast to the A6-c134:Tax/HLA-A2 complex, the major stabilizing interaction in RD1-MART1
complexes appeared to be the insertion of a tryptophan side chain from RD1-MART1 (W101α in the
3QDG/DMF5 orientation or W98β in the 3HG1/Mel5 orientation) into the extra space provided by the
highly curved topology of the MART1 peptide (Fig. 2.1 b, 2.2 a-b). This insertion of a tryptophan side
chain was not observed in the 4FTV/A6-c134 or 3QDM/DMF4 orientations (Fig. 2.7), a finding also sup-
ported by calculations of the solvent accessible surface area (Fig. 2.8). This suggests that the 4FTV/A6-c134
and 3QDM/DMF4 orientations are unlikely to represent optimally bound configurations for the complex, and
that the more probable mode of interaction is similar to those observed in the 3QDG/DMF5 or 3HG1/Mel5
crystal structures. The exclusion of a 3QDM/DMF4-like orientation is further consistent with the structural
data, as the DMF4 TCR does not use the Vα2 gene segment. The 4FTV/A6-c134 and 3QDM/DMF4 ori-
entations were also characterized by a counter-clockwise rotation (when viewed from the top of the TCR)
with regard to the other two orientations. The orientation in 3QDG/DMF5 (but not 3HG1/Mel5) allows
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FIGURE 2.2 (c) Insertion of tryptophan W101α of RD1-MART1 into the interface between MART1 and HLA-A2
in the 3QDG/DMF5 orientation. (d) Insertion of tryptophan W98β of RD1-MART1 into the interface between
MART1 and HLA-A2 in the 3HG1/Mel5 orientation. (e) Salt-bridge interactions that occur in the 3QDG/DMF5
orientation of the RD1-MART1:MART1/HLA-A2 complex. (f) The absence of tryptophan insertion in RD1-MART1
when Tax replaces MART1 in the HLA-A2 complex (4FTV/A6-c134 orientation).
12
FIGURE 2.3 Root mean square deviation (RMSD) of the CDR3β modeled positions 99-102 (based on the A6 wild
type crystal structure, PDB: 1AO7) over 40 ns. The A6-c134 crystal structure (4FTV) was employed as the reference.
An RMSD of ¡1.5 Å suggests a good side chain overlap with respect to the crystal structure at the indicated positions.
Raw data is shown in lighter color, and the block-averaged data is shown by the darker line.
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FIGURE 2.4 MD simulation of modeled A6-c134 CDR3β loop. (a) Overlay of the backbone configurations of the
A6-wt MSAQ trajectory are shown in red, with the starting A6 wild type configuration (green) and A6-c134 crystal
structure (blue). (b) Side chain orientations of an A6-wt MSAQ trajectory configuration (RMSD of 0.6 Å) compared
to their orientations in the A6-c134 crystal structure (4FTV).
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FIGURE 2.5 MD of DMF5 TCR Residue F100β. (a) Snapshots of F100β from the simulations compared with
the original crystal structure conformation. The conformation of F100β from the crystal is shown in red; starting
conformation shown in yellow; final conformation shown in cyan and intermediates shown in cyan with stick represen-
tation. (b) Root mean square deviation (RMSD) of the heavy atoms in F100β side-chain from the crystal structure
orientation. (c) χ1 and χ2 dihedral angles of F100β. For both (b) and (c) raw data is shown in lighter color, and
the block-averaged data is shown by darker lines.
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the establishment of two salt bridges, K55α with E154MHC of HLA-A2 and D56β with R65MHC of HLA-A2,
which have interaction probabilities of 51.1% and 97.5%, respectively (Fig. 2.2c and 2.6). Thus, although
both 3QDG/DMF5 and 3HG1/Mel5 orientations show tryptophan insertion, only the former orientation
simultaneously maintains both of these inter-domain salt bridges, making the 3QDG/DMF5 orientation
more likely to be representative of the complex (Fig. 2.2b,c). These CDR2 interactions (K55α/E154MHC
and D56β/R65MHC) have been described in several TCR complexes (24, 40), and they help facilitate the
conserved TCR diagonal orientation observed for most TCR:pepMHC complexes (13, 53)
FIGURE 2.6 Molecular dynamics predicted interactions between TCR and peptide or MHC. The colors indicate
the probability of strong interaction, which is measured by the fraction of time residues interact with a distance less
than 3.5 Å during the simulation. The size of each marker is also proportional to the interaction probability. The
optimal interaction distance during interactions is indicated on the Y-axis.
It is interesting to note that the DMF5:MART1/HLA-A2 structure (PDB: 3QDG), similar to the modeled
RD1-MART1:MART1/HLA-A2 complex, also contains the Vα2 region, MART1 and HLA-A2. Although the
TCR (DMF5) in the 3QDG/DMF5 structure does not contain a tryptophan in either CDR3, a phenylalanine
at position 100 in the CDR3β inserts into the same area as the MART1/HLA-A2 ligand as predicted by
the MD simulations (Fig. 2.9). Rosetta sequence tolerance algorithms also showed a strong preference for
tyrosine and phenylalanine at position F100β. Although the salt bridges described above are not present,
R65MHC of HLA-A2 plays a key role, as it does in most other complexes (15, 53).
Finally, we examined what would happen if MART1 were replaced by Tax in the MD simulations of
the RD1-MART1:MART1/HLA-A2 complexes. In this simulation, the tryptophan insertion could not be
established due to the different backbone topology of the Tax peptide (Fig. 2.2d). In addition, neither
of the salt bridges mentioned above formed and the triple hydrogen bonding pattern observed in the A6-
Tax/HLA-A2 complex was absent in the MD simulation of the RD1-MART1:Tax/HLA-A2 complex. In
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FIGURE 2.7 Molecular dynamics of interactions of alternative RD1-MART1 orientations. No significant hydropho-
bic interactions exist between W98β and W101α and MART1 peptide when RD1-MART1 is in (a) 4FTV/A6-c134-
orientation or (b) 3QDM/DMF4- orientation.
addition, when MART1 is replaced by Tax in a model of the complex with A6-c134, A6 was found in the
simulation to lose not only the triple hydrogen bonds, but also the D98α-K66MHC salt bridge. Collectively,
these effects probably account for the differential affinity of A6 and RD1-MART1 for MART1/HLA-A2 and
Tax/HLA-A2. The results of these MD simulations will require crystal structures to verify.
Discussion
The peripheral T-cell repertoire is shaped by positive and negative selection in the thymus, whereby T cells
with TCRs that do not bind to self-pepMHC, or with TCRs that bind too strongly, are deleted (10, 11). The
wild-type TCRs that have been isolated and characterized biochemically and structurally have been derived
from T cells that have made it through these stringent in vivo selection processes. In this study, we created
repertoires of TCRs in yeast display libraries that could be selected for pepMHC binding in vitro without
the in vivo ’filters’ that are involved in thymic or peripheral T-cell processes. We believe that this in vitro
selection approach can provide additional information about the fundamental basis of pepMHC specificity of
TCRs. In addition, the strategy represents a high-throughput system to generate specific TCR leads against
the thousands of potential targets represented by viral or cancer peptides, without the need to isolate T-cell
clones for each one.
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FIGURE 2.8 Molecular dynamics of solvent accessible surface area in modeled complexes. Hydrophobic interactions
between (a, c) W98β or (b, d) W101α and the peptide-MHC complex, indicated by solvent accessible surface area
(relative). A6-c134 and RD1-MART1 TCR are abbreviated as A6 and RD1, respectively.
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FIGURE 2.9 Overlay of RD1-MART1 models and the DMF TCR. Superposition of the DMF5 TCR with RD1-
MART1 in the 3QDG/DMF5-orientation and RD1-MART1 in the 3HG1/Mel5-orientation, using the MHC as an
alignment reference. The key aromatic residue at position 98β (for the 3HG1/Mel5-orientation) and 101α (for the
3QDG/DMF5-orientation) are highlighted in red and green, respectively. The aromatic F100β of the aligned DMF5
TCR crystal structure is in yellow. The MART1 peptide in each structure or model is shown with matched color.
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Our primary goal in the present study was not to affinity mature a wild-type TCR against its cognate
antigen (28–33, 36–39), but to use directed evolution to isolate TCRs with novel specificities against non-
cognate antigens. We chose the human TCR A6 as an initial scaffold based on the wealth of information
available and previous findings that it is amenable to yeast display and directed evolution34. The A6 TCR
recognizes at least three distinct HLA-A2-restricted ligands, Tax (LLFGYPVYV), derived from HTLV-1,
and two structural mimics of Tax called Tel1p (MLWGYLQYV) and HuD (LGYGFVNYI)6,15,49. Studies
of A6 binding to these and various other mutant Tax peptides have shown significant plasticity in CDR3
loops to accommodate a variety of substitutions in the Tax structure (54–56).
Two different libraries of the A6 TCR resulted in TCR variants that bound to the non-cognate antigen
MART1/HLA-A2. To the best of our knowledge, this is the first report of ‘switching’ the specificity of a
TCR to a completely different peptide by directed evolution. The MART1-specific TCRs from both of the
libraries contained similar mutations within the CDR3 loops. In RD1-MART1, a tryptophan (98β) replaced
the leucine of the wild-type A6 TCR and mutagenesis showed that the W98β played a key role. In RD2-
MART1, a tryptophan at position 101 of the CDR3α was selected and it is possible that it functions in a
manner similar to the W98β. In RD1-MART1 a lysine was selected at position 98 of the CDR3α, whereas in
RD2-MART1 an arginine was selected at position 102 of CDR3β. Strikingly, the affinity-matured variant of
RD1-MART1 (RD1-MART1HIGH ) evolved four residues in CDR3β (MAGG, 99-102) that were also selected,
in a one-amino-acid register shift in the RD2-MART1 clone (MAGG, 98-101). A structure of these mutants
will be required to fully understand the underlying molecular basis of MART1 specificity.
The two different libraries reported here also yielded higher-affinity TCRs for binding to the Tax/HLA-
A2 complex. Here, as with the MART1-specific clones, there was strong selection for specific residues in
the CDR3β, including four residues at positions 99-102 (MSAQ), which have been identified previously as
yielding a high-affinity phenotype. However, in the context of these residues, there was also strong selective
pressure for Tax binding evidenced in the preference for residues in CDR3α. For example, four CDR3α
residues within the two different libraries (T98 and D99 in RD1, and S100 and W101 in RD2) were highly
restricted in Tax selections and these are the same residues found in the wild-type A6 TCR. This finding
supports the idea that both CDR3 loops operate in concert to provide specificity, and higher affinity, for
Tax.
Interestingly, WT1-specific TCRs were not isolated, despite the presence at position 8 in both Tax and
WT1 of a tyrosine that is predicted to be a key residue for binding by A6 (25). The absence of TCR variants
that bound WT1 among the A6 libraries again supports the view that multiple regions across the TCR
interface are involved in conferring specificity (that is, not only those near the Y8 in these two peptides). It
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is possible that alternative libraries, with degeneracies in other CDR residues, could yield solutions to WT1
binding.
The basis of the specificity switch from Tax to MART1 was also investigated by MD simulations of known
structures, or of models of the selected TCRs docked onto structures of these pep/HLA-A2 ligands. MD
has previously been used to assess the role of conformational heterogeneity in TCR/pepMHC interactions
(55, 57). To validate the use of MD simulations to probe functionally relevant TCR:pepMHC interactions,
we performed several analyses (see Results), which were in agreement with previously reported results
using a variety of biophysical and mutational approaches (24, 25). The simulation results indicate that
major interactions between the A6 TCR and the Tax/HLA-A2 complex involved Tax residues Y5 and Y8,
and HLA-A2 residue R65, along with key TCR residues S31α, T98α, D99α, E30β and L98β. Interestingly,
although CDR3α residues T98 and D99 interacted with R65/K66 of HLA-A2 and they were highly conserved
in selection with Tax/HLA-A2, this restriction was completely dependent on the peptide. Thus, selection of
the RD1 library with MART1 yielded only CDR3α residues K98 and Y99, which must provide very different
modes of interaction with the MART1/HLA-A2 complex.
The MD simulations of the RD1-MART1 TCR revealed a quite striking mode of interaction that could
account for a substantial binding difference between MART1 and Tax complexes. A tryptophan in either
CDR3α or CDR3β was inserted into the space created by the curved position of the MART1 backbone,
providing significant hydrophobic stabilization. This positioning also oriented the outside of the periphery
of the TCR-binding surface, through the two CDR2 loops, to form two salt bridges (one with each HLA-A2
helix). The specificity of RD1-MART1 for MART1 was accounted for in part by the inability of Tax to
accommodate this tryptophan conformation and thus to allow optimal orientation and interaction between
the TCR and the Tax/HLA-A2 complex.
One of the libraries (RD2) yielded TCR variants that were cross-reactive with different pep/HLA-A2
ligands. These cross-reactive clones were selected with either non-cognate ligand, MART1/HLA-A2 or
WT1/HLA-A2. The sequences of the cross-reactive clones revealed diversity, but highly restricted residues
were selected at particular positions of CDR1α, CDR3α and CDR3β. The consensus sequence of these
clones, as represented by clone RD2-WT1, involved the following five residues: I26α, S28α, R100α, S101α
and V98β. To gain insight into the basis of the binding of these cross-reactive TCRs and their peptide
independence, Rosetta Backrub models were generated for various complexes of this canonical mutant TCR,
based on the A6 structure. The wild-type A6:Tax/HLA-A2 structure was compared with the models of
the RD2-WT1 TCR in complex with Tax/HLA-A2, MART1/HLA-A2 or WT1/HLA-A2. None of the five
residues in A6 were < 3.2 Å from the nearest HLA-A2 residues, although several were involved in contacts
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with Tax. In striking contrast, all five of the RD2-WT1 residues were predicted to be positioned within 3.2
Å of the HLA helices, including the following paired residues (TCR residue:HLA-A2 residue(s)): I26α:E58,
S28α:Y59/W167, R100α:A69/Q72, S101α:R65 and V98β:T73.
The highly restricted nature of each of these residues in the cross-reactive TCRs across three different
loops suggests that they act in concert to contribute to binding of the HLA-A2 molecule. Importantly, all
five residues are predicted to be at a sufficient distance from each peptide to avoid steric clashes that would
prevent binding. T cells that expressed TCRs such as these RD2 clones would probably have been negatively
selected in the thymus. In fact, relevant to this, transgenic mice containing a single pepMHC as selecting
ligand yielded T cells with TCRs that exhibited similar cross-reactive behaviour (58). In addition, the highly
restricted sequences of these TCRs, and those selected with specificity for Tax or MART1, are analogous to
the dominance of some TCRs that arise from positive selection on self-peptides in the thymus (11, 59)
In summary, using a single TCR scaffold we have shown that it is possible to generate novel TCRs against
non-cognate pepMHC ligands. To improve the likelihood of isolating specific TCRs de novo against other
peptide/HLA-A2 complexes (such as WT1), several approaches can be applied to the design of additional
libraries, including the use of a collection of TCR templates with different Vα2 and Vβ regions, degeneracies
at other CDR positions and the use of synthetic CDR3 loops with varying amino acid lengths. In addition, it
may be possible to start with TCRs such as RD2-WT1 that have a basal affinity for most peptide/HLA-A2








The majority of fast excitatory neurotransmission is initiated by α-amino-3-hydroxy-5-methyl-4-isoxazole
propionic acid (AMPA)-sensitive ionotropic glutamate receptors in complex with modulatory auxiliary sub-
units (60, 61). Transmembrane AMPA receptor regulatory proteins (TARPs) (62), the most widespread and
well-studied family of auxiliary proteins, alter AMPA receptor gating kinetics, ion channel properties, and
pharmacology (63). The prototypical TARP, deemed stargazin or TARP γ2, potentiates AMPA receptor
activity by decelerating deactivation and desensitization kinetics, facilitating recovery from desensitization,
boosting the efficacy of partial agonists, and attenuating polyamine block (64–66).
AMPA receptors have a modular architecture with synaptically localized amino terminal domains (ATDs)
and ligand-binding domains (LBDs), an ion-channel-forming transmembrane domain (TMD), and a cyto-
plasmic domain (CTD) (67, 68) Studies on isolated receptor domains and intact receptors have illuminated,
at high resolution, how agonists induce local “clamshell” closure of the LBDs and how the LBDs are arranged
as nonequivalent pairs of A/C and B/D dimers within an overall 2-fold symmetric LBD “gating ring” (69–
72) Although crystallographic and cryoelectron microscopy (cryo-EM) structures of intact receptors have
been determined in the presence of partial and full agonists (5, 73, 74), no studies have yet captured the
ion channel gate in an open conformation. Indeed, the X-ray studies suggest that, upon receptor activation,
not only does the LBD gating ring expand, but it also moves closer to the TMD (5, 73). However, these
structural studies were carried out on thermostabilized receptor variants with low open probabilities, where
the ion channel gate remained closed, thus suggesting that, despite gating ring expansion, “compression” of
the LBD toward the membrane bilayer decoupled agonist-binding from ion channel gating.
Studies on isolated domains and on the intact receptor have also provided insights into the structural
underpinnings of receptor desensitization. Cysteine mutagenesis and electrophysiological studies carried
1Reproduced in part with permission from the journal Cell. S. Chen, Y. Zhao, Y. Wang, M. Shekhar, E. Tajkhorshid, and
E. Gouaux. Cell, 170: 1234-1267 (2017). Some data shown in the following figures were provided by the research group of
Prof. Eric Gouaux: figure 3.1 and panel A of figure 3.3.
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out on the intact and ∆ATD receptors, along with crystallographic studies on the isolated LBD “dimers,”
suggested that rupture of the LBD dimer D1-D1 interface was sufficient to promote receptor desensitization
(75). By contrast, cryo-EM studies of isolated AMPA receptors and the closely related kainate receptors
suggest that there are, instead, large-scale rearrangements of the LBD layer from 2-fold to ∼4-fold symmetry
(74, 76). A low-resolution X-ray study of an intact AMPA receptor, as well as cryo-EM studies, are also
suggestive of large-scale LBD rearrangements upon receptor desensitization (5)
At present, there are no structures of an AMPA receptor with an open ion channel gate, nor are there
studies of the AMPA receptor-TARP complex in multiple ligand-bound conformations. Moreover, there are
no structural insights into the conformational ensemble of structures associated with an AMPA receptor-
TARP complex upon receptor desensitization. To gain insight into how TARP subunits modulate receptor
activity, from increasing the efficacy of partial agonists to altering the properties of the ion channel pore, we




Prior to the MD studies, MDFF was used as part of the structure refinement process (8). During the MDFF
refinements, the generalized Born implicit solvent model (77) was used with a 150 mM ionic strength. A
1 fs time step was used with van der Waals interactions evaluated every 2 fs and electrostatic interactions
every 4 fs. Two-fold symmetry restraints were applied to the protein Cα atoms with a sprint constant of
1 kcal/mol/Å2/atom. Chirality and secondary structure restraints were applied to the protein. A density
map derived grid-fore potential was applied to protein heavy atoms. Each heavy atom was assigned with a
virtual charge of +1 and a scaling factor equal to its atomic mass. The structure was energy-minimized for
400 steps and simulated for 80 ps.
MD simulation setup
Three types of MD simulations were performed: classical MD, steered MD (SMD) (78), and confined MD
(CMD). In SMD simulations, the open-state structure resolved in this study excluding the LBD was used
as the initial structure. Side-chain conformations were optimized using SCWRL4 (79, 80). Residue E191
from the TARP was protonated based on pKa estimation suing PROPKA 3.1 (81). Residue 586 (Q/R site)
(82) can be either Q or R, depending on RNA editing, and both variant were simulated in SMD. Simulation
of the Q variant is denoted as “Q” hereafter. Due to the ambiguity of the protonation state of Arg586, we
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explored all possible variants of protonation states of the four side-chains, resulting in different net charges:
0 (R0), +1 (R1), +2 (R2a and R2b, referring to neighboring and diagonal positioning, respectively), +3
(R3), and +4 (R4).
In all simulations, the protein was first embedded in a pure POPC lipid bilayer and solvated with TIP3P
water (83), and 150 mM NaCl. Then the systems (∼244,000 atoms, 160 Å × 160 Å × 110 Å) were energy-
minimized for 500 steps and simulated for 0.5 ns at 310 K with all protein heavy atoms and lipid phosphorus
atoms harmonically restrained (k = 5 kcal/mol/Å2) to relax the lipid tails. This step was then followed by
a 4 ns membrane relaxation, only restraining the Cα atoms from the well structured (helix/β-sheet) regions
(k = 50 kcal/mol/Å2). An electric potential of -100 mV (negative at the cytoplasmic side) was added to
all simulations to represent the membrane potential. In SMD simulations, starting from an equilibrated
system, one Na+ ion was placed near Ala621 at the beginning of the simulation and was steered toward the
cytoplasmic side along the membrane normal at a constant velocity of 0.2 Å/ns and using a spring with (k
= 20 kcal/mol/Å2) for 64.5 ns. No restraining forces were applied in the XY plane. An additional SMD
simulation (84.5 ns) of the Q variant (without LBD/TARP) was also performed to explore the entire pore
region between the extracellular side and the channel central cavity, where an ion was initially placed 4 Å
above Ala621 and followed the same SMD protocol stated above.
To gain enhanced sampling of Na+-Thr617 interactions, CMD simulations were also performed in which
two harmonic potentials were used to confine the ion to the region near Thr617. Using NAMD grid forces
(84), two half harmonic potentials (k = 50 kcal/mol/Å2) were added, one near Thr617 (3 Å below its Cα)
and another 4 Å above it, respectively. Two Q/R site variants (Q and R0) were simulated for 64.5 ns each.
To test the ion permeability, classical MD simulation of the Q variant was performed for 89 ns with Cα
atoms restrained (k = 1 kcal/mol/Å2) in the presence of 500 mM NaCl with -300 mV membrane potential
following the same system preparation protocol.
In addition, to measure the hydration profile of the channel lumen, classical MD simulations of the
closed structure (PDB: 3KG2) and the open-gate structure reported here were performed for 24.5 ns each.
Missing loop regions in the closed structure were modeled using MODELLER (85). Furthermore, a short
MD simulation (100 steps of energy minimization and 5 ns equilibration) of one Na+ and one Cl− ion in
bulk water (50 Å × 50 Å × 50 Å) was also performed as a control to quantify the hydration of an isolated
Na+ ion. The last 4 ns of this simulation was used for radial distribution function calculation of Na+ and
the oxygen of the water, as well as the average number of water in the first hydration shell of Na+.
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Simulation protocol
All simulations were performed with NAMD2 (86) using the CHARMM36 force field (2016/07 release) for
both protein (87) and lipids (88), with correction to the van der Waals interactions between Na+ and the
carboxyl oxygen atoms in protein, as well as the lipid phosphate oxygen atoms and carboxyl oxygen atoms
(89). The isothermal-isobaric ensemble (NPT) was applied to all simulation systems. Periodic boundary
conditions were used in all three dimensions. The average simulation temperature was controlled by the
Langevin thermostat algorithm (48), with a damping coefficient of 5 ps−1. The average temperature was
kept at 101,325 Pa using the Nosé-Hoover-Langevin method (90, 91), with a piston period of 200 fs and
piston oscillation decay time of 100 ps. Long range electrostatic interactions were calculated using the
particle mesh Ewald method (92, 93), with a grid spacing of 1 Å. The time step was 2 fs for short-range
non-bonded interactions and 4 fs for long-range electrostatics interactions. The conjugated gradient (51)
with line-searching algorithm (52) was used for energy minimization.
Analysis of Na+-accessible region
The asymmetry in the shape of the region inside the lumen available to the Na+ ion (Na+-accessible region)
was defined as the ratio between the standard deviation of the Na+ trajectory along the first and second
principal axis during the SMD simulation. First principal component analysis (PCA) of the XY plane
project of the first 2 ns trajectory (10,000 data points) of the steered Na+ ion was performed. The first and
second eigenvectors (sorted by decreasing eigenvalues) were chosen as the first and second principal axes,
respectively. The coordinate system of the data points was changed to the one defined by the ratio between
the standard deviations along the X and Y axes were calculated, the asymmetry at other Z locations was
calculated by sliding a sub-sampling window (10,000 data points) along the entire trajectory. The orientation
of the Na+-accessible region was defined as the angle between the first principal axis and the X axis from the
coordinate system of the simulation and calculated using the sliding sub-sampling windows defined earlier.
Results and Discussion
Architecture of the ion channel pore
The density throughout the receptor TMD, including the M2 pore helix, the pore “loop” and the canonical
M3 gating helices of the quisqualate/(R,R)-2b-bound complex, is well defined, allowing us to reliably position
main-chain and bulky side-chain groups, thus defining the most complete structure of an AMPA receptor ion
channel pore to date (Fig. 3.1 A). This improved structural model for the pore region reveals key residues
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that stabilize the pore architecture and define ion channel properties. The M2 helices and the pore loop are
largely positioned by interactions with the M1 and M3 helices within a subunit and from the M1 helix of
an adjacent subunit, contacts mediated in part by aromatic residues resolved in the density map (Fig. 3.1
B). Trp605 (M3), Tyr533 (M1), and Trp605 from an adjacent subunit form hydrophobic interactions with
the C-terminal end of the M2 helix, whereas Phe541 (M1) stabilizes the N terminus of the M2 helix (Fig.
3.1 B). These well-defined interactions in the receptor TMD are in part due to the indirect interactions
with TARP via contacts between receptor M1 and M4 helices with TARP TM3 and TM4 elements. Indeed,
superposition of the isolated receptor TMD with the receptor TMD from the TARP complex shows that the
presence of TARP results in a large-scale adjustment of receptor TMD interactions that not only allow for
extensive receptor-TARP interactions but that also reduce the conformational mobility of the receptor M2
helix and pore loop (Fig. 3.3 A).
The storied Q/R site, discovered by Seeburg and colleagues (82), harbors an arginine in the present
construct, and the four arginine residues are located at the apex of the pore loop (Fig. 3.1 A). Density for
the β-carbon of Arg586 allows us to define the orientation of the side-chain (Fig. 3.1 B), thus suggesting
that the side-chains project into the central vestibule (Fig. 3.1 A), in agreement with the reduction in
block by cationic toxins, small molecules, and cytoplasmic polyamines (94–98). The location of the arginine
guanidine groups also provides a logical explanation for the calcium impermeability of GluA2 (Arg586)-
containing AMPA receptors (99) due to charge-charge repulsion.
The M2-pore loop region of the quisqualate/(R,R)-2b complex is 2-fold symmetric (Fig. 3.1 C), in
contrast with the 4-fold symmetric pore helices found in the MPQX-bound complex, suggesting that the
pore structure is not independent of structural rearrangements related to complex activation. Interestingly,
the pore symmetry is unaltered in potassium channels upon gate opening, perhaps because a glycine residue
(Gly99 for KcsA) present in the gating helix functions as a hinge (100), largely decoupling conformational
changes associated with gating from movements of the pore helix and pore loop. The equivalent position
in AMPA and kainate receptors is replaced by a threonine (Thr609 for GluA2 receptors) (Fig. 3.1 B).
We speculate that this renders the M3 helices more rigid, thus coupling movements of M3 helices to the
structural elements of the pore via extensive M2-M3 interactions.
The M3 bundle crossing in the quisqualate/(R,R)-2b complex forms a two-fold symmetric pore (101)
that is more dilated along the B/D direction in comparison to the A/C direction, breaking the ∼4-fold
symmetry observed in the antagonist-bound complex. To estimate whether this gate is sufficiently open to
allow for ion permeation, we measured distances between Cα atoms of opposing residues including Thr617,
Ala621, Thr625, and Met629 and compared them with corresponding distances measured from an inactive
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and closed GluA2 receptor (71). The Cα atom distances increase by 2 Å, 2 Å, 3 Å, and 14 Å at Thr617,
Ala621, Thr625, and Met629 between A and C subunits, respectively, and by 2 Å, 4 Å, 20 Å, and 14 Å
between B and D subunits. These distance increases, together with the calculation of the solvent accessible
pathway along the pore axis (102), show that the pore constriction, or gate, has expanded and that Thr625
and Met629 no longer hinder ion-permeation (Fig. 3.1 A). However, the “gate region” at the M3 bundle
crossing is not as open as in the open state of potassium channels (103), and thus, we argue that the
quisqualate/(R,R)-2b-bound GluA2-TARP γ2 complex represents a partially open, ion-conductive state.
Changes in ion-permeability upon state transition
The resolution of the experimentally resolved active state structure of the AMPA receptor is 4.9 Å, which
limits the precision on the estimation of pore size. To investigate the ion permeability upon the transition
from the closed state to the active state, a series of classical simulations were carried out on the previously
resolved crystal structure (with Q at the Q/R site residue 586) (closed state, PDB: 3KG2) (71) and the active
state structure (with R586Q mutation). The hydration patterns indicate that the closed state structure is
impermeable to water in the lumen region between residue T617 (z = -2 Å) and A621 (z = 6 Å) (Fig. 3.2 A
inset, red). However, a significant number of water molecules were found at this region during the simulation
of the active state structure based on the average number of lumen water molecules (Fig. 3.2 A inset, blue)
as well as the lumen water occupancy map (Fig. 3.2 B, translucent isosurfaces). Spontaneous entry of a
Na+ ion into the pore lumen (central chamber) is observed within 10 ns in an MD simulation, which further
supports the notion that the channel gate is sufficiently open to allow permeation of hydrated Na+ ions (Fig.
3.2 A). The selectivity filter has a narrower pore than the channel gate in the quisqualate/(R,R)-2b-bound
structure (Fig. 3.3 B). However, this region opened up slightly during the simulation as indicated by the
minimum pore radius (Fig. 3.3 C). The radius of the most restricted section increased up to ∼2 Å (Fig. 3.3
B), consistent with flexibility of the selectivity filter loop structures.
Asymmetric water and ion accessible region inside channel lumen
To gain deeper insight into the mechanism of ion permeation and ion-protein interactions, we employed
steered MD (SMD) simulations to induce permeation of one Na+ ion through the gating region of the open-
channel structure. Interestingly, the water occupancy isosurface shows strong asymmetry along the lumen
(Fig. 3.2 B). The region between the extracellular side and Ala621 is elongated toward the B/D subunits,
while the region between Ala621 and Thr617 was elongated toward the A/C subunits. The region visited
by the permeating Na+ ion (Na+ accessible region) exhibited the same asymmetry pattern (Fig. 3.2 B).
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FIGURE 3.1 Ion channel pore of the active-state AMPA receptor structure. (A) view of LBD/TMD layers and,
in inset, close-up of the TMD region showing receptor TMD, TM3-4 of TARP, and solvent accessible pathway of the
ion channel pore, along the central 2-fold axis (dashed line). In the inset, only two subunits are shown. A/C and
B/D subunits are colored in green and salmon, respectively, with the pore loops highlighted in yellow. Cα atoms of
Arg586 (Q/R site) and Thr617 are shown as blue and gray spheres, respectively. Pore radii calculated without the
side-chain model of Arg586 are depicted by purple, green, and red dots, representing pore radii of > 3.3 Å, 1.8-3.3 Å,
and < 1.8 Å, respectively. (B) M2 helices are stabilized through hydrophobic side-chain interactions with adjacent
M1 and M3 helices. M2 helices are represented as cartoon in transparent solvent accessible surfaces. Structurally
well-resolved side chains are shown in licorice representation. Cα atoms of key glycine residues in M3 are defined by
gray spheres. (C) extracellular side view of the M2 helices and the pore loops (P loop). Centers of mass, as well as
the inter-helix distances and angles are labeled.
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FIGURE 3.2 Permeability of the ion channel pore at the active-state. (A) The spontaneous ion permeation
trajectory of a Na+ during the MD simulation of the active structure (with R586Q mutation). The number of
water molecules in the TMD lumen averaged over the last 20 ns of the MD simulations of active state structure
(Quis+(R,R)-2b) and closed state structure (MPQX, PDB: 3KG2). (B) Asymmetric accessible regions inside the
TMD channel lumen available to water (translucent surface) and Na+ (yellow dots) revealed by the steered molecular
dynamics (SMD) trajectory. The 30% water occupancy isosurface is shown as translucent surfaces. The trajectory
of the permeating Na+ ion is shown as yellow dots.
The measured asymmetry showed that the Na+-accessible region near Ala621 was symmetric (Fig. 3.3 D),
likely due to the hydrophobicity of its side chain. By contrast, the Na+-accessible region near Thr617 was
elongated (Fig. 3.3 D). Close inspection of the region near Thr617 reveals that the asymmetry is caused by
favorable interactions of the Na+ with the individual hydroxyl groups of the lining Thr617 side chains (Fig.
3.3 E). These interactions also lead to a rotation of the longitudinal axis of the Na+-accessible region by
90◦ at Thr617 (Fig. 3.3 F). We further note that the side-chain orientations of Thr617 from the A/C chains
changed during these ion-permeation simulations, while those from the B/D chains retain their original
conformation (Fig. 3.4 A), likely underlying preferential interaction between the Na+ ion and Thr617 from
the A/C chains.
The average number of first-shell water molecules surrounding the permeating Na+ was 5.2, compared
to 5.7 in bulk water, throughout most of the pore (region above Thr617 Cα) but dropped by 1 unit upon
interacting with Thr617 (Fig. 3.4 B and Fig. 3.4 C). A second drop in ion hydration occurred at ∼2 Å below
Thr617, caused by interactions with the hydroxyl group of Thr617 from chain B (Fig. 3.2 B). This is also
supported by inspecting the relation between the number of solvation shell water molecules around Na+ and
the minimum distance between Na+ and the hydroxyl oxygen of Thr617 (Fig. 3.4 D), a solvation metric that
decreases when Na+ is close to the oxygens of one of the Thr617 residues. The asymmetric distributions of
water and ions within the pore were reproducibly observed in all simulations performed, despite differences
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in initial configurations, namely the presence of arginine or glutamine at site 586 or different protonation
states of the four Arg586 residues (see Methods).
FIGURE 3.3 The Pore Structure and Ion Permeation Patterns of GluA2 at the Active State. (A) TMD com-
parison between GluA2-TARP γ2 complex bound with quisqualate/(R,R)-2b and the isolated receptor bound with
fluorowillardiine-(R,R)-2b. All helices are shown as cylinders and the isolated receptor is colored in gray. (B) Pore
radius profile along the central pore. The average pore radius is shown in gray with standard deviations shown
as translucent gray area. The pore radius profile for the starting conformation and the most open conformation
during the simulation is shown in blue and red respectively. The selectivity filter region is highlighted in yellow.
(C) Minimum central pore radius (measured by the HOLE program) of the GluA2-TARP γ2 complex during the
classical simulation where spontaneous ion permeation was observed. The running average is shown as a thick gray
line. The yellow region highlights the frame with the maximum opening. (D) Asymmetry of Na+ accessible region
in the SMD simulation, with the Thr617 region and Ala621 region highlighted in yellow.
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FIGURE 3.4 The Hydration Patterns, and Ion Permeation Patterns of GluA2 at the Active State. (A) Changes
in the Z coordinates of the steered Na+ and the four Thr617 hydroxyl oxygens with running averages shown as
thick lines. (B) Radial distribution function of water oxygens surrounding the Na+ ion based on the last 4 ns of
equilibrium MD simulation of a pair of Na+ and Cl− in bulk water. The boundary of the first solvation shell is
at 3.15 Å (blue dashed line). (C) Changes in the number of solvation shell water surrounding the steered Na+ at
different Z level. The average number of solvation shell water for Na+ in bulk water is 5.7 (dashed line) based on the
simulation mentioned in (B). The Thr617 region is highlighted in yellow. (D) same as (C) but with respect to the
minimum distance between Na+ and Thr617.
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Chapter 4





It may be argued that the ultimate goal of structural biology as applied to ion channels is to provide a
picture of what the protein looks like in its different physiologically relevant conformational states. Although
by no means the “whole story,” it seems that little could be done without this information if we wish to
understand the physicochemical bases of ion-channel function. Remarkable advances have been made toward
the structural characterization of ion channels in the last two decades. However, the assignment of well-
defined functional states to the obtained structural models—a crucial aspect of the entire endeavor—has
proved more elusive than anticipated and is often a matter of controversy.
Undoubtedly, the problem arises because protein structure cannot typically be studied under the same
conditions that are used to study protein function. For example, whereas the functional properties of an ion
channel are usually assessed in the context of a phospholipid membrane at room temperature, structure is
frequently determined in detergent micelles at cryogenic temperatures, often under the constraints imposed
by a crystal lattice. Furthermore, whereas the functional effect of channel-activating stimuli is often assessed
under nonequilibrium conditions (say, right after the application of a ligand-concentration jump), the effect
of such stimuli on structure is—with only rare exceptions (104)—studied at much longer times, too long to
be reached during electrophysiological recordings, once the conformational equilibrium has presumably been
attained. Thus, in the face of such disconnect between structural and functional studies, some authors choose
to predict the functional state of structural models on the basis of electrophysiological observations, whereas
others make a judgment simply on the basis of what the structures look like, irrespective of functional
considerations. In our view, both approaches have their own limitations, and we can imagine situations in
which both may lead to wrong conclusions.
One aspect of channel function that benefits greatly from structural information is ion permeation. In
1Reproduced in part with permission from the Journal of General Physiology. G. Gonzalez-Gutierrez, Y. Wang, G. D.
Cymes, E. Tajkhorshid, and C. Grosman. J. Gen. Physiol. In press. (2017) DOI: 10.1085/jgp.201711803. Some data in the
following figure panels were provided by the research group of Prof. Claudio Grosman: Fig. 4.1, Fig. 4.2 C, Fig. 4.7 B, and
Fig. 4.8 B
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the particular case of the pentameric ligand-gated ion channels (pLGICs), for example, decades of electro-
physiological experiments—starting with, say, the seminal work of Imoto and coworkers (105) and Galzi
and coworkers (106)—have led to a fairly sophisticated understanding of the determinants of single-channel
conductance (107) and charge selectivity (108), and it seems to us that little can be advanced at this point
by simply adding more electrophysiological observations. In our opinion, further knowledge will emerge from
the application of molecular simulations, and for these to have any realistic meaning, an appropriate model
of the open-channel structure must be used.
Models of the open-channel conformation of pLGICs (at resolutions better than 4.0 Å) have been pro-
posed for the bacterial ligand-gated ion channel from Gloeobacter violaceus at pH 4.0 (GLIC; Protein Data
Bank (PDB) ID code 4HFI; resolution, 2.4 Å; X-ray crystallography; (109)), the Caenorhabditis elegans α1
glutamate-gated Cl– channel (α1 GluCl) bound to glutamate and ivermectin (PDB ID code 3RIF; 3.35 Å;
X-ray crystallography; (110)), the C. elegans α1 GluCl bound to ivermectin alone (PDB ID code 3RHW;
3.26 Å; X-ray crystallography; (110)), and the zebrafish α1 glycine receptor (α1 GlyR) bound to glycine
(PDB ID code 3JAE; 3.9 Å; single-particle electron cryomicroscopy; (111)). A comparison of these struc-
tures reveals that, at the level of the transmembrane pore—and disregarding the side chains, which differ
among members of the superfamily—the models of GLIC and GluCl are very similar to each other, whereas
the model of the glycine-bound GlyR is considerably wider, especially at the intracellular end. The mean
distances between the axis of ion permeation and the Cα atoms at the narrowest constriction of the pore
(position -2′) differ by ∼2 Å in these two classes of model. This difference in size is particularly relevant for
studies of ion permeation because the channel’s charge-selectivity filter is formed precisely by this constric-
tion and because the filter’s diameter is expected to affect conductance and selectivity. The assignment of
these four structural models to the open-channel conformation was made, essentially, on the basis of pore
size. Indeed, in all four cases, the transmembrane-pore lumen was deemed to be wide enough for hydrated
or partially dehydrated monovalent ions to go through. However, when functional considerations are also
taken into account to guide the interpretation of the data, a conflict arises because GLIC at pH 4.0, for
example, desensitizes nearly completely in a matter of a few seconds (112) and the α1 GlyR fully bound to
glycine does so in a matter of a few minutes (113, 114) —of course, when embedded in a cell membrane.
Needless to say, this is orders of magnitude faster than the kinetics of crystal growth.
Perhaps adding more confusion, a model of the zebrafish α1 GlyR bound to both glycine and ivermectin
has also been recently generated (PDB ID code 3JAF; 3.8 Å; single-particle electron cryomicroscopy; (111)).
As shown in Fig. 4.1 A, the Cα profile of this model’s second transmembrane segment (M2) α-helices relative
to the pore axis lies somewhere in between those of the narrower open-channel pores of GLIC and GluCl on
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the one hand, and the wider open-channel pore of the GlyR bound to glycine alone on the other. However,
at the level of the most intracellular turn of M2 (that is, where the charge-selectivity filter is), the model
of the GlyR bound to both glycine and ivermectin is much closer to the narrower models than it is to the
wider one.
In an attempt to make sense out of this multiplicity of open-channel models, the narrower-pore confor-
mation has recently been reclassified as a “partially open or desensitized-like” state (111). It is unclear,
however, how one would reconcile such a partially open conformation with what is known about these chan-
nels because sojourns in open-channel low-conductance states are rare and very short-lived in single-channel
recordings from pLGICs (115, 116). Also, it is unclear how the properties of a desensitized-like conformation
would differ from those of a genuine desensitized conformation.
In hopes of shedding some light on this confusing situation, we crystallized two variants of GLIC (at
pH 4.5) carrying the highly open-channel stabilizing isoleucine-to-alanine mutation at position 9′—in the
middle of M2—and solved their structures. Furthermore, we performed all-atom molecular dynamics (MD)
simulations of ion permeation and picrotoxinin block using the different structural models of pLGICs pro-
posed to represent the open-channel conformation. On the basis of these results, we favor the idea that the
open-channel structure of pLGICs—with the likely exception of the ligand-gated ion channel from Erwinia
chrysanthemi (ELIC), which seems to form atypically wide pores (117)—is much closer to the structural
models of GLIC at pH ∼4.0, GluCl bound to ivermectin, GluCl bound to glutamate and ivermectin, and the
GlyR bound to glycine and ivermectin (that is, the narrower models) than it is to the model of the GlyR
bound to glycine alone.
Methods
Simulation system preparation
Four structural models of pGLICs were studied computationally: (1)GLIC C27S + K33C + I9′A + N21′C
at pH 4.5 (new crystal structure in this work; termed GLIC-o); (2) GLIC Y27′A at pH 4.0 (PDB ID
code 4LMK; termed GLIC-c) (118); (3) zebrafish α1 glycine receptor GlyR, with glycine bound (PDB ID:
3JAE, termed GlyR-w) (111); (4) the same GlyR but with both glycine and ivermectin bound (PDB ID:
3JAF, termed GlyR-n) (111). Since the goal of the simulations is to study the ion permeation property
of the transmembrane lumen region, the extracellular domains were omitted for both ELIC and GlyR. The
region included in the simulations for GLIC was from residue P195 to P317, and from residue Q235 to
V364 for GlyR. For the GlyR bound to glycine alone (PDB ID: 3JAE), the linker residues G327 and T328
between helix M3 and M4 were missing from original structure and thus not included in the simulation
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FIGURE 4.1 Different open-channel models. (A) Distances between the axis of ion permeation and the Cα atoms
for residues in the pore-lining M2 α-helices of five different structural models of pLGICs (mean ± standard deviation
of all subunits; error bars smaller than the symbols were omitted). IVM, ivermectin. Solid lines are cubic-spline
interpolations. The two GluCl profiles are nearly indistinguishable from each other. A comparison of pore dimensions
including the side chains (as could be obtained using HOLE (102), for example) seems unwarranted here because
the different models correspond to members of the superfamily with different amino acid sequences. The lumen of
the pore is to the right of the plot. (B) Alignment of M2 α-helix sequences of the three pLGICs compared in A.
Identical residues are indicated with an orange background.
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model. The residues at position 21′ of GLIC-o and at position 27’ of GLIC-c were modeled according to
their wild type sequence using in silico mutation performed by the psfgen module from VMD (119). The
N-terminus and C-terminus residues of all models were patched with CAHRMM ACE and CT2 neutralizing
patches, respectively (120).
There are several ionizable residues in both GLIC and GlyR. In the absence of experimental information
about their side-chain pKa values, aspartic acid and glutamate acid residues were assumed be negatively
charged, while lysine and arginine residues were assumed to be positively charged. Little is known about the
effect of positively and negatively charged residues on the single-channel conductance of GLIC or GlyR, but
data on the muscle nicotinic acetylcholine receptor (AChR) predicted that only the protonation states of
ionizable residues at the intracellular end of the M2 helix (i.e., E(−2)’ from GLIC and R0’ from GlyR) have
a major effect on the rate of ion conduction. Since the pH of the intracellular solution is typically held at
neutral pH during electrophysiological recordings, these residues can be reasonably assumed to retain their
protonation states same as in bulk solution.
The two models of the bacterial channel GLIC were embedded in 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoethanoamine (POPE) membranes, and the two models of eukaryotic receptor GlyR were embed-
ded in 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) membranes (see details at Membrane-patch
preparation). Each prepared membrane patch was combined with the corresponding membrane protein, and
later solvated and ionized (150 mM KCl for GLIC and 150 mM NaCl for GlyR). Protein side-chain rotamers
were optimized using SCWRL4 (80). Missing atoms in protein residue side chains were recovered using the
psfgen module from VMD (119). The final system size was (150-160) Å × (150-160) Å × (95-100) Å with
∼200,000-220,000 atoms.
Nonequilibrium simulation of pore expansion
The conductance of GlyR-n was much less than expected. To explore the conductance of GlyR with wider
pore sizes, we designed a new protocol based grid-steered molecular dynamics (GSMD) (84). The initial
system with was prepared using the same protocol as the equilibrium simulations with 500 mM NaCl. Then
the system was energy-minimized for 500 steps and equilibrated for 400 ps to relax the lipid tail group
atoms, with protein heavy atoms and lipid phosphorus atoms harmonically restrained (k = 1 kcal/mol/Å2).
In the following 5 ns, lipids were free to equilibrate around the protein whose backbone heavy atoms were
restrained (k = 1 kcal/mol/Å2). After these equilibration steps, the system was simulated using GSMD for 1
ns. A customize grid potential was designed for this GSMD, which had highest potential at the center of the
channel and radially decreased along the XY plane at a linear rate of 1 kcal/mol/Å. There are no changes
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in grid potentials along the Z direction. Only the Cα atoms from residues 266-270 (M2 positions from -2′
to 2′) were coupled to the grid potential, with a grid scaling factor of 2 or 3. Cα atoms from other protein
residues with helical secondary structures were harmonically restrained (k = 1 kcal/mol/Å2). In addition, to
prevent distortion in protein secondary structures, all residues in the helical region were retrained, including
hydrogen bonds (k = 20 kcal/mol/Å2), angles (k = 20 kcal/mol/deg2), and dihedral s (k = 200 kcal/mol).
In addition, to preserve the 5-fold symmetry, a symmetry restraint (121) was applied to all Cα atoms in the
helical region (k = 2 kcal/mol/Å2).
New membrane-patch preparation protocol
The most difficult step in preparing a protein-membrane system is creating a proper membrane-lipid interface.
The simplest method is to superimpose the protein and the membrane, and then remove any lipids having
steric clashes with the protein. To optimize the interface region, a new method was developed based on the
atom selection by density map feature from VMD (119) as described below. (1) the protein was centered
around the origin and oriented such that the vector from the intracellular domain to the extracellular domain
was aligned to the Z axis. (2) a simulated density map of target protein was generated at a resolution of
3 Å using the MDFF module from VMD (119). (3) generate a membrane bilayer along the XY plane and
centered around the origin. (4) superimpose the simulated density map and the membrane and remove any
lipids with at least one atom inside the high-density region (density value ¿ 0.8), or inside the pore lumen
region. The cutoff density value depends on the target protein, and should be manually adjusted for each
new target. Minor steric clashes can be allowed, which will be removed in the next step. (5) to remove
minor steric clashes, the membrane patch from the last step is subjected to an implicit solvent simulation
using the generalized Born model (77, 122–128) with 100 mM ionic strength and dielectric constant 80. The
cutoff radius of all Born radii was 14 Å. The cutoff radius for nonbonded interactions is 16 Å. A switching
function was used to generate a smooth transition to zero interaction potential at the cutoff distance, which
took effect at 15 Å. A short list of nonbonded interaction partners for each atom was used to increase the
efficiency of short-range nonbonded interaction calculations, which had a cutoff distance of 17 Å and was
updated very 40 fs (20 steps). The physical time corresponding to one MD step was 1 fs. Short-range
nonbonded interactions were updated every 4 fs, while long range electrostatic interactions were updated
every 8 fs. The Langevin thermostat algorithm ( damping coefficient = 1 ps−1) was used to maintain the
average temperature around 310 K and hydrogen atoms were excluded from the thermal control. To resolve
the steric clashes, a 3-Å resolution repulsive grid potential was design by generating a simulated density map
of the target protein using the MDFF module from VMD (119), where potential values were calculated by
38
adding many 3D Gaussian potentials centered at each atom from the protein. Then grid-steered molecular
dynamics (GSMD) was carried out on the membrane patch with all lipid heavy atoms coupled to the grid
potential. Each coupled atom had a pseudo-charge of 1 elementary charge. Lipid molecules that were 60 Å
away from the membrane patch center were harmonically restrained (k = 1 kcal/mol/Å2). This restraint
was necessary to maintain the membrane edge shape because periodic boundary conditions under implicit
solvent condition were not fully supported by NAMD. The system was energy-minimized for 1000 steps and
then simulated using GSMD for 50 ps. The resulting lipid conformation from the last trajectory frame was
used for subsequent steps of protein-membrane system assembly.
Molecular dynamics (MD)
All systems were simulated under the isobaric-isothermal ensemble (NPT). The average temperature was
maintained at 310 K using the Langevin thermostat (damping coefficient 1 ps−1) (48). The average pressure
was maintained around 101,325 Pa using the Nosé-Hoover-Langevin algorithm (90, 91) with an oscillation
period of 100 fs and a damping time of 50 fs. Each system was energy-minimized for 500 steps using the
conjugated-gradient algorithm (51) combined with line searching (52). A 400 ps simulation was carried out to
relax lipid tail group atoms, with lipid-phosphorus atoms and protein heavy atoms harmonically restrained
(k = 1 kcal/mol/Å2).Then each system was simulated with only the protein backbone heavy atoms restrained
(k = 1 kcal/mol/Å2). The root mean square deviation (RMSD) for all protein backbone heavy atoms with
respect to the initial conformation was always below 0.41 Å throughout the entire simulations. All chemical
bonds involving hydrogen atoms were constrained using the SETTLE algorithm (44). The time for each MD
integration step was 2 fs. Nonbonded interactions were separated into short-range and long-range regions.
For van der Waals and electrostatics interactions, the cutoff radius for short-range interactions was 12 Å.
To achieve a smooth decay of nonbonded interactions to zero at the cutoff distance, a switching function
(129) was applied to both nonbonded interactions which took effect at 10 Å. Pairwise nonbonded interaction
partners searching was accelerated by using a pair-list with a cutoff radius of 13.5 Å and was updated every
40 fs (20 MD integration steps). Long-range electrostatics interactions were calculated using the Particle
Mesh Ewald algorithm (45–47). Short-range nonbonded interactions were updated every 2 fs, while long-
range nonbonded interactions were updated every 4 fs. All simulations were performed using NAMD 2
(86, 130, 131). CHARMM36 force field (08/2014 release) was used for both the proteins (120) and lipids
(88). The van der Waals interactions between Na+ and the oxygen atoms from protein carboxylate groups
and lipid carboxylate, carboxylate-ester, and phosphate-ester groups were specifically customized (89).
Picrotoxinin (C15H16O6) was used to test the drug blocking effect on GlyR. The initial structure of this
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toxin was obtained from a crystal structure of the α-1 GluCl channel (PDB ID: 3RI5) (110) and placed
into both the GlyR-w and GlyR-n systems after aligning to the GluCl structure using the Cα atoms of the
transmembrane region. The force field parameters for picrotoxinin was obtained from CGenFF (132, 133).
No restraints were applied to the toxin during the simulations.
Pore-radius profile analysis
All pore-radius profiles were calculated using HOLE (102) with parameter file “simple.rad”.
Results
Ion conduction in GLIC
It could be said that our experimental evidence for a particular structure of the pore in the open-channel
conformation is not any stronger than that supporting the much wider pore observed for the glycine-bound
GlyR (PDB ID code 3JAE). Certainly, after all, both types of model resulted from the application of
structural methods to detergent-solubilized pLGICs. Also, although the I9′A mutation favored the open-
channel conformation of membrane-embedded GLIC at the pH at which the crystals grew, the lack of
a phospholipid membrane in the crystals, and the vastly different time scales of the electrophysiological
observations and the crystallization process, made us wonder about the limitations of our results. Moreover,
our own previous attempts to favor the open-channel conformation of the bacterial pLGIC ELIC, also using
gain-of-function mutations, failed to change the channel’s conformation in crystals (134). To address these
concerns, we decided to examine the different structural models of the open-channel conformation of pLGICs
using all-atom molecular dynamics simulations of ion permeation and block.
We started by simulating ion permeation through the structural model of the double-cysteine + I9′A
mutant of GLIC (Fig. 4.2, 4.3). To make the system computationally more tractable, we simulated only
the transmembrane domain of the pentamer—namely, the stretch between Phe 195 (at the N-terminus of
M1) and Phe 317 (the most C-terminal residue) of each of the five subunits. To limit the drift of the
simulated system away from the initial structure, we applied restraints to the protein-backbone heavy atoms
throughout the simulations (for all simulated systems and all ion-permeation MD simulations performed in
this work, the RMSD remained below 0.41 Å). We embedded this reduced model in a POPE membrane facing
symmetrical 150 mM KCl solutions at 37◦C. We chose to use K+ rather than Na+ because the experimentally
estimated single-channel conductance of K+-carried currents is larger than that of Na+-carried currents in
the cation-selective pLGICs (107, 136), and because we expected to record few cation crossings through
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FIGURE 4.2 MD simulations of ion permeation through the structural model of the disulfide-reduced GLIC C27S
+ K33C + I9′A + N21′C mutant. The membrane was bathed by symmetrical 150 mM KCl, and the temperature was
37◦C. (A) Ion trajectories at -100 mV. (B) Ion trajectories at -200 mV. In A and B, only the trajectories of ions that
crossed the membrane are plotted. In these plots, gray areas indicate the regions occupied by the membrane in the
periodic-simulation system, and downward transitions of the ion trajectories through these regions represent inward
crossings. The darker lines are running averages of the data, which are displayed in a lighter shade. The length of
the simulation box along the z-axis was 108 Å. (C) Current–voltage relationship from simulations performed at -100
mV, -200 mV, and -500 mV; ion trajectories at -500 mV, and the corresponding MD pore-radius profile, are shown
in Fig. 4.4.
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FIGURE 4.3 Pore radius profiles for GLIC the open and closed states. (A) Pore-radius profiles (estimated using
HOLE (102)) of structural models of the disulfide-reduced quadruple mutant. The profile of the crystal-structure
model (PDB ID code 5V6N; this work) is compared with those computed during the ion-permeation MD simulations
illustrated in A and B. (B) Pore-radius profiles of structural models of the closed-channel conformation. The profile of
the crystal-structure model (PDB ID code 4LMK (118)) is compared with that computed during an ion-permeation
MD simulation at -100 mV. In C and E, ion-permeation-MD pore-radius profiles are mean profiles—displayed as
the mean (darker lines) ± 1 standard deviation (SD) (lighter shade)—calculated from the different frames of each
simulation; the vertical axes extend, approximately, between M2 positions -3′ (bottom) and 21′ (top). Side-chain
rotamers were optimized using SCWRL4 (135) before the ion-permeation simulations were run.
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GLIC at physiologically relevant membrane potentials. We chose POPE for these simulations because this
phospholipid is a major component of Gram-negative bacterial membranes (137), whereas we typically use
POPC bilayers for eukaryotic proteins (138). Importantly, the fact that backbone atoms were restrained
during our simulations of ion permeation (see Methods) minimizes the impact of the particular choice of
phospholipid on protein dynamics.
At -100 mV (negative on the intracellular side) and in 180 ns of simulation, we observed 2 K+ and no
Cl− crossings (Fig. 4.2 A). Two cation crossings in the same direction (here, from the extracellular side to
the intracellular side) in 180 ns represent an inward current of approximately -1.8 pA, and -1.8 pA at -100
mV under symmetrical salt concentrations across the membrane (such that, at zero voltage, the current is
zero) correspond to a single-channel conductance of 18 pS (Fig. 4.2 C). Considering the short duration of
the simulations, the low number of permeation events, and the fact that only the transmembrane domain
of the channel was included in the simulations, a value of 18 pS compares favorably with the value of ∼9
pS estimated from single-channel currents recorded between -40 mV and -100 mV at room temperature
with ∼150 mM Na+ on the extracellular side and ∼150 mM Cs+ on the intracellular side of outside-out
patches (109). Furthermore, during this simulation at -100 mV, one K+ (labeled as K+(3) in Fig. 4.2 A)
entered the pore from the extracellular side and moved all the way to its intracellular end before returning
back to the extracellular solution. At more hyperpolarized potentials (for which there are no experimental
counterparts), the number of K+ crossings in 180 ns simulations was 9 at -200 mV (Fig. 4.2 B and C, and
52 at -500 mV (Fig. 4.2 C and Fig. 4.4 A), all in the inward direction; no Cl− crossings were observed.
Thus, collectively, these results favor the idea that the structural models of GLIC generated here represent
an ion-conductive conformation—probably the fully protonated open-channel conformation. Note, however,
that the side-chain–rotamer optimization procedure that preceded the ion-permeation MD simulations (see
Materials and methods), as well as the simulations themselves, led to a pore that is narrower than suggested
by the (static) crystal-structure model (Fig. 4.3 A and Fig. 4.4 B); it is this narrower pore that supported
the reported number of ion crossings. We also performed analogous simulations using a structural model of
GLIC in a conformation that we have deemed to represent the fully protonated closed-channel state (PDB
ID code 4LMK; (118); Fig. 4.3 B); we observed no ion crossings in 180 ns at -100 mV.
Throughout these MD simulations, all five glutamate side chains of the charge-selectivity filter (at position
-2′, in the particular case of GLIC) were kept deprotonated and free to sample all possible dihedral angle
combinations. It may be argued that the probability of glutamate side chains being negatively charged
decreases at the acidic pH that is used to open the channel. This point is of relevance in the context of
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FIGURE 4.4 MD simulation of ion permeation through the structural model of the disulfide-reduced C27S + K33C
+ I9′A + N21′C mutant at -500 mV. The membrane was bathed by symmetrical 150 mM KCl, and the temperature
was 37◦C. (A) Ion trajectories. For clarity of display, the trajectories of the 38 K+ that crossed the membrane at
least once in the simulated ∼180 ns were displayed in four separate panels. Of these 38 K+, 27 crossed the membrane
inward once, 8 did so twice, and 3 did so three times. Because no Cl− crossings were observed during the simulated
time, these 52 net K+ inward crossings represent an approximate inward current of -46 pA. Only the trajectories of
ions that crossed the membrane are plotted. The gray areas indicate the regions occupied by the membrane in the
periodic-simulation system, and downward transitions of the ion trajectories through these regions represent inward
crossings. The darker lines are running averages of the data, which are displayed in a lighter shade. The length of
the simulation box along the z-axis was 108 Å. (B) Pore-radius profiles (estimated using HOLE (102)) of structural
models of the disulfide-reduced quadruple mutant. The profile of the crystal-structure model (PDB ID code 5V6N;
this work) is compared with that computed during the ion-permeation MD simulation illustrated in A. The latter is
the mean profile—displayed as the mean (darker lines) ± 1 standard deviation (lighter shade), calculated from the
different frames of the simulation; the vertical axis extends, approximately, between M2 positions -3′ (bottom) and
21′(top). Side-chain rotamers were optimized using SCWRL4 (135) before the ion-permeation simulation was run.
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effect on the computed single-channel conductance (139). However, it should be noted that position -2′ is
at the intracellular end of the pore, and that the intracellular solution is typically kept at nearly neutral pH
during electrophysiological recordings; it is the extracellular pH—not the intracellular one—that switches.
This makes the prediction of protonation states much less straightforward not only because the pKa values
of these glutamate side chains are unknown in GLIC but also because the pH of the solution around them
is less well defined under the asymmetrical extracellular–intracellular pH conditions used to activate the
channel (140). Nevertheless, it is clear that the pH value that needs to be used to predict the protonation
state of these intracellular glutamates is much closer to 7.0 than it is to 4.5. Regarding the freedom of these
glutamate side chains to sample torsional space, we argue that we do not have experimental evidence for
their conformations being restricted to a particular subset of rotamers as we do, instead, for the glutamates
at position -1′ of the muscle AChR (107, 141).
Ion conduction and block in the α1 GlyR
In single-channel recordings from the GlyR in the presence of picrotoxin (a mixture of picrotoxinin [C15H16O6]
and picrotin [C15H18O7], two toxic plant compounds), open-channel intervals are shortened in a manner that
is consistent with the phenomenon of ion-channel blockade by these organic molecules (142, 143). We rea-
soned that we could use the current-blocking properties of picrotoxinin in MD simulations of ion permeation
to help us identify which structural model is more likely to represent the open-channel conformation. The
open-channel model is expected to be wide enough to let ions permeate, yet narrow enough for ion perme-
ation to be completely blocked when bound to picrotoxinin. On the other hand, a nonconductive pore would
be too narrow to pass currents even in the absence of picrotoxinin, whereas a model of an overly dilated
pore would still pass currents in the presence of this molecule.
We started by simulating the model of the glycine-bound GlyR (PDB ID code 3JAE; Fig. 4.5, 4.6). As
was the case for GLIC, only the transmembrane domain of each subunit was included in the simulations
(from Gln 235 to Val 364), and restraints were applied to the protein-backbone heavy atoms throughout
the simulations. We embedded this reduced model in a POPC bilayer facing symmetrical 150 mM NaCl
solutions at 37◦C. At -100 mV and in 180 ns of simulation, we observed 25 Cl− moving outward (i.e., from
the intracellular to the extracellular side) once, 6 Cl− moving outward twice, and 3 Cl− moving outward
three times, for a total of 46 outward crossings (Fig. 4.5, A and B). Also, during the simulation, one Cl−
moved inward once, and another Cl− moved inward first and outward ∼50 ns later. Thus, the number of net
Cl− crossings in 180 ns at -100 mV was 45. Because no Na+ crossings were observed during the simulated
time, this number of Cl− outward crossings represents a single-channel conductance of ∼400 pS, whereas the
45
FIGURE 4.5 MD simulations of ion permeation through the structural model of the glycine-bound α1 GlyR. The
membrane was bathed by symmetrical 150 mM NaCl, and the temperature was 37◦C. (A) Ion trajectories at -100 mV.
For clarity of display, the trajectories of the 36 Cl− that crossed the membrane at least once in the simulated 180 ns
were displayed in three separate panels. (B) Pore-radius profiles (estimated using HOLE (102)) of structural models
of the glycine-bound GlyR. The profile of the cryo-EM-structure model (PDB ID code 3JAE) is compared with that
computed during the ion-permeation MD simulation illustrated in A. The latter is the mean profile—displayed as the
mean (darker lines) ± 1 standard deviation (lighter shade), calculated from the different frames of the simulation;
the vertical axis extends, approximately, between M2 positions -3′ (bottom) and 21′ (top). Side-chain rotamers were
optimized using SCWRL4 (135) before the ion-permeation simulation was run.
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FIGURE 4.6 MD simulations of ion block in the structural model of the glycine-bound α1 GlyR. The membrane was
bathed by symmetrical 150 mM NaCl, and the temperature was 37◦C. (A) Ion trajectories at -100 mV computed for
the glycine-bound GlyR model with a molecule of picrotoxinin placed in the pore. In A and D, only the trajectories
of ions that crossed the membrane are plotted. In these plots, gray areas indicate the regions occupied by the
membrane in the periodic-simulation system, and upward transitions of the ion trajectories through these regions
represent outward crossings. The darker lines are running averages of the data, which are displayed in a lighter shade.
The length of the simulation box along the z-axis was 95.5 Å. (B) Stick representation of the molecule of picrotoxinin
(C15H16O6); carbon atoms are cyan, oxygens are red, and hydrogens are white. The mesh representation shows the
solvent-accessible surface of the toxin calculated using a 1.5 Å probe radius and with van der Waals radii taken from
HOLE (102) parameter file simple.rad. (C) Snapshot from the ion-permeation MD simulation of the 3JAE model
at -100 mV with a molecule of picrotoxinin placed in the pore. The permeation trajectory of a Cl− ion is shown as
green spheres. The molecule of picrotoxinin is shown in van der Waals representation, and the 30% water-occupancy
isosurface is shown as transparent shapes. For clarity, only two nonadjacent chains are shown.
experimentally observed value around -100 mV for the full-length α1 GlyR at room temperature is ∼95–100
pS. We then placed picrotoxinin (Fig. 4.6 B) in the pore of this GlyR model in such a way that the toxin
adopted essentially the same pose and position as those inside the pore of the picrotoxinin-bound model of
GluCl (PDB ID code 3RI5; (110)). Although the toxin decreased the simulated current, its blocking effect
was far from complete. Indeed, 10 outward Cl− crossings (and no Na+ crossings) were still recorded in 180
ns at -100 mV (Fig. 4.6, A and C; and Fig. 4.9 A), which corresponds to a single-channel conductance of
∼89 pS. Certainly, the lumen of the pore was wide enough for Cl− to slip by the molecule of the tumbling
toxin and traverse the pore. The diameter of this model’s pore at its narrowest constriction (including the
side chains and disregarding the molecule of picrotoxinin) is ∼8.5 Å (Fig. 4.5 B and Fig. 4.9 A). The mean
effective size of picrotoxinin was 5.7 Å in diameter, during the simulation—calculated by subtracting the
pore radius profile with the toxin from that without the toxin.
We then simulated the model of the glycine-and-ivermectin–bound GlyR (PDB ID code 3JAF; Fig. 4.7,
Fig. 4.8). As was the case for the glycine-bound model, only the transmembrane domain of each subunit was
included in the simulations (from Gln 235 to Val 364, with protein-backbone heavy-atom restraints applied),
and this reduced model was embedded in a POPC bilayer facing symmetrical 150 mM NaCl solutions at
37◦C. At -100 mV and in 240 ns of simulation, no ion crossings were observed despite the overall similarity
47
FIGURE 4.7 MD simulations of ion permeation through the structural model of the glycine-and-ivermectin–bound
α1 GlyR. (A) Ion trajectories at -100 mV through an expanded version of the cryo-EM-structure model (PDB
ID code 3JAF) obtained using grid-steered MD (84). The membrane was bathed by symmetrical 150 mM NaCl,
and the temperature was 37◦C. Only the trajectories of ions that crossed the membrane are plotted. Gray areas
indicate the regions occupied by the membrane in the periodic-simulation system, and upward transitions of the ion
trajectories through these regions represent outward crossings. The darker lines are running averages of the data,
which are displayed in a lighter shade. The length of the simulation box along the z-axis was 84 Å. (B) Single-
channel current–voltage relationships of the (full-length) rat α1 GlyR at ∼22◦C. The recordings were obtained in the
cell-attached patch-clamp configuration from transiently transfected HEK-293 cells. The pipette solution contained
∼150 mM Cl−. Taurine is a partial agonist of the α1 GlyR, whereas glycine is a full agonist.
between this model’s Cα profile and that of our open-channel model of GLIC. Analysis of pore-radius profiles
indicated that the side-chain-rotamer optimization procedure and the MD simulation itself had decreased
the pore’s narrowest constriction from ∼5.0 Å (in diameter) in the cryo-EM structural model to a mean
value of ∼4.4 Å during the simulation. Thus, suspecting that the narrowing of the pore’s constriction may
have rendered this model nonconductive, we proceeded to expand the pore so as to recover, approximately,
its original size. To this end, we applied an outward force to the five M2 α-helices using grid-steered MD
(grid-scaling factor = 2; (84)). MD simulations of ion permeation through this new model in the presence
of 500 mM NaCl yielded only one Cl− outward crossing during 20 ns at -500 mV, and none during 40 ns at
-200 mV; at its narrowest constriction, this model’s mean diameter was ∼5.2 Å throughout the simulation.
We then proceeded to expand the pore even more by applying a larger outward force to M2 (grid-scaling
factor = 3). In ion-permeation MD simulations of this additional model at -100 mV and in the presence
of 150 mM NaCl, we observed seven outward Cl− crossings (and no Na+ crossings) in 180 ns (Fig. 4.7
A). This number of outward Cl− crossings through this zebrafish GlyR model represents a single-channel
conductance of ∼62 pS, which compares favorably with the experimentally estimated values of ∼95–100 pS
for the (full-length) rat α1 GlyR in the cell-attached configuration with ∼150 mM Cl− in the pipette solution
(Fig. 4.7 B) and ∼80–88 pS for the homo-oligomeric-like GlyR of the zebrafish larva Mauthner cell in the
outside-out configuration with nearly symmetrical ∼150 mM Cl− (144). At its narrowest constriction, this
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FIGURE 4.8 Channel pore radius profile, Cα profile, and toxin block simulation of the structural model of the
glycine-and-ivermectin–bound α1 GlyR. (A) Pore-radius profiles (estimated using HOLE (102)) of structural models
of the glycine-and-ivermectin–bound GlyR. The profile of the cryo-EM-structure model is compared with those
computed during MD simulations of ion permeation through a partially expanded version and the expanded version
of the 3JAF model. Ion-permeation-MD pore-radius profiles are mean profiles—displayed as the mean (darker lines)
± 1 standard deviation (lighter shade)—calculated from the different frames of each simulation; the vertical axis
extends, approximately, between M2 positions -3′ (bottom) and 21′ (top). Side-chain rotamers were optimized using
SCWRL4 (135) before the ion-permeation simulations were run. IVM, ivermectin. (B) Cα profiles of the cryo-EM-
structure model and the expanded version. For clarity, the Cα profile of the partially expanded model was omitted; it
lies somewhere in between those displayed. In the case of the expanded 3JAF model, the profile was calculated for a
randomly chosen frame of the ion-permeation MD simulation. The five subunits of each model were averaged. Error
bars (omitted if smaller than the symbols) are standard errors. Solid lines are cubic-spline interpolations. The lumen
of the pore is to the right of the plot. (C) Snapshot from the ion-permeation MD simulation of the expanded model
at -100 mV with a molecule of picrotoxinin placed in the pore. No ion crossings were recorded through this system.
The molecule of picrotoxinin is shown in van der Waals representation, and the 30% water-occupancy isosurface is
shown as transparent shapes. For clarity, only two nonadjacent chains are shown.
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model’s mean diameter was ∼5.8 Å throughout the simulation. The reasons why the model with an ∼5.2-Å
narrowest constriction (the “partially expanded” model; Fig. 4.8 A) displayed such a low conductance in
simulations are unclear. What is clear, however, is that the model with an ∼5.8-Å narrowest constriction
(the “expanded” model; Fig. 4.8, A and B) is wider by only ∼0.6 Å, and that its computed single-channel
conductance is comparable to the experimentally estimated value. Consistent with the notion that the
expanded model represents an open-channel structure, no ion crossings were observed when picrotoxinin was
placed in the pore and the system was simulated for 180 ns at -100 mV in the presence of 150 mM NaCl
(Fig. 4.8 C and Fig. 4.9 B). During this simulation, the mean effective size of the tumbling toxin was 5.6 Å
in diameter. Note that, at the level of backbone atoms, the cryo-EM 3JAF model of the GlyR, its expanded
version, and the two models of I9′A GLIC at pH 4.5 presented here are all very similar to one another,
especially toward the intracellular end of the transmembrane pore (Fig. 4.8 B).
Glycine-bound a1 GlyR (3JAE)
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FIGURE 4.9 Pore-radius profiles of picrotoxinin-bound models of the α1 GlyR. (A) The profile of the
cryo-EM-structure model of the glycine-bound GlyR (PDB ID code 3JAE) is compared with that computed during
the MD simulation of ion permeation through the 3JAE model with a molecule of picrotoxinin placed in the pore.
PTX, picrotoxinin. (B) The profile of the cryo-EM-structure model of the glycine-and-ivermectin–bound GlyR (PDB
ID code 3JAF) is compared with that computed during the MD simulation of ion permeation through the expanded
3JAF model with a molecule of picrotoxinin placed in the pore. IVM, ivermectin. In A and B, ion-permeation-MD
pore-radius profiles are mean profiles—displayed as the mean (darker lines) ± 1 standard deviation (lighter shade),
calculated from the different frames of each simulation upon removing the modeled molecule of picrotoxinin; the
vertical axes extend, approximately, between M2 positions -3′ (bottom) and 21′ (top). Side-chain rotamers were
optimized using SCWRL4 (135) before the ion-permeation simulations were run.
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Discussion
Nearly 20 years after the first X-ray crystal structure of a detergent-solubilized ion channel was unveiled
(145), it seems as though the ambitious goal of providing pictures of what these proteins look like in their
different physiologically relevant conformational states has not been fully attained, yet. Although methods
for engineering, overexpressing, purifying, crystallizing, and imaging ion channels have become increasingly
powerful, the approaches followed to assign well-defined functional states to the obtained structural models
have remained, for the most part, overly simplistic. Indeed, there seems to be no reason why one should
expect that the lack of a membrane or the presence of a (rigid) crystal lattice have no effect on the con-
formational free-energy landscape of a membrane protein (146–151) Moreover, it seems that judging the
conductive versus non-conductive nature of an ion-channel structural model solely on the basis of what the
pore lumen looks like may be misleading because mechanisms more subtle than simple steric occlusion are
also expected to gate the flow of ions in biological channels (152, 153).
It is with these caveats in mind that we set out to determine the structure of the open-channel confor-
mation of fully ligand-bound pLGICs. To decide between the “narrow-pore” and “wide-pore” competing
models (Fig. 4.1), we crystallized a variant of the bacterial channel GLIC (at pH 4.5) bearing a mutation that
markedly stabilizes the open state relative to the closed and desensitized states. Although the effect of this
mutation on GLIC could not be assessed unequivocally at the single-channel level, the macroscopic currents
were consistent with the well-characterized open-channel stabilizing effect of this mutation on the pLGICs
from animals. The solved structures favor the notion that the model with a narrower pore is the one that
more closely represents the open-channel conformation of animal pLGICs. The model of the GlyR bound
to glycine, on the other hand, seems too dilated at the intracellular end of the transmembrane pore—that
is, where the determinants of charge selectivity and single-channel conductance lie.
Aware, however, of the limitations of assigning a functional state to a structural model of a detergent-
solubilized ion channel on the basis of its behavior when embedded in a membrane, we performed MD
simulations of ion permeation and picrotoxinin block. These results pointed to the same conclusion as did
our structural data: the narrower-pore models seem more likely to represent the open-channel conformation
of animal pLGICs. If this functional assignment were correct, it would be unclear which end state of a
pLGIC’s conformational free-energy landscape the wider-pore model corresponds to, and what its occupancy
probability in vivo is. Certainly, there is no electrophysiological evidence for the existence of two (or more)
open-channel conformations with widely different single-channel conductance in pLGICs. Although single-
channel recordings from human (154) and rat (155) α1 GlyR homomers heterologously expressed in HEK-293
cells often show more than a single high-occupancy open-channel current level, these are so closely spaced
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that it seems unlikely that they reflect the interconversion of pore structures as different as those represented
by the glycine-bound and the glycine-and-ivermectin–bound GlyR models. Thus, although we cannot rule
out the possibility that both conformations coexist in the membrane, it seems prudent to assume that one
of them is much more populated than the other, and therefore, is more representative of the open state.
Whereas much effort has been devoted to optimizing the biochemical steps leading to the preparation
of membrane proteins suitable for X-ray crystallography or electron cryomicroscopy, comparatively little
attention has been paid to the challenging problem of assigning functional states to structural models. In
this paper, we aimed to contribute to this aspect of ion-channel structural biology in two different ways:
1. by engineering mutations with extreme effects on the relative stabilities of the different end states—in
hopes of overcoming the eventually competing energetic effects of detergent solubilization and crystal-lattice
formation; and 2. by performing computer simulations of ion permeation and block. We would like to
emphasize, however, that we do not mean to imply that now we know what the open-channel conformation of
pLGICs exactly looks like. Indeed, we are fully aware of the theoretical and practical limitations of computer
simulations, and we realize that inferring the functional state of a detergent-solubilized membrane protein
on the basis of its behavior in a membrane usually involves a great deal of speculation (112, 156). Moreover,
we would not find it surprising if the fine details of the open-channel structure differed among different
pLGICs, even at the level of backbone atoms. In fact, within the class of narrower-pore models, the Cα
profiles of GLIC and GluCl are very similar to each other, whereas that of the glycine-and-ivermectin–bound
GlyR is clearly different toward the extracellular half. However, what seems to be abundantly clear from
our work is that narrower-pore models, as a group, are a much better starting point to understand ion
permeation and other properties of the open-channel conformation of animal pLGICs than is the—much
different—wider-pore model.
Undoubtedly, a more detailed understanding of a protein’s conformational free-energy landscape, the
application of nonequilibrium approaches to imaging proteins, and the routine incorporation of computa-
tional tools such as those described here will help fill the vexing gap between the structural biology and




in the BetP Membrane Transporter
1
Introduction
The majority of the import and export of metabolic substances into living cells occurs at cellular membranes
via membrane embedded proteins: membrane transporters, channels and carriers. Membrane transporters
are usually identified by their signature substrate transport mechanism called alternating access mechanism,
where the lumen of the transporter only open to one side at a time but not both. This means the transporter
can only have three possible stable states: inward facing, outward facing and occluded states. Membrane
channels on the other hand can also occupy an additional open state where the substrate can freely cross the
membrane through the channel lumen. The tight control of transport state is explained by three possible
mechanisms: the rocker switch, rocking bundle and the elevator mechanisms based on decades of structural
and functional characterization of a variety of transporters. Despite these significant progresses, a complete
description of the transitions between the three major states are yet to be discovered for most transporters
with rare exceptions (cite recent SWEET transporter study published in Cell 2017).
There are two types of membrane transporters depending on the energy source: the primary transporter
(ATP hydrolysis driven) and secondary transporter (cross membrane concentration gradient driven). The
typical substances that provides the concentration gradients are ions (K+, Na+, etc.) and protons, with
the latter relatively harder to study experimentally. In this paper, we present computational studies of the
proton coupling mechanism for substrate transport in one of the structurally best characterized secondary
membrane transporter BetP with a single mutation (G153D). Earlier study have shown that this single
mutation is able to convert the wild type BetP from a Na+ gradient coupled betaine transporter into a
proton gradient coupled choline transporter (157). The well documented extensive structure studies of BetP
provides an excellent opportunity for probing the proton coupled substrate mechanism in general.
Soil bacteria cells (e.g. Corynebacterium glutamicum) rely on certain membrane transporter proteins to
absorb osmolytes from the environment to prevent dehydration. One example is BetP, a Na+ coupled betaine
1This chapter is currently in preparation for submission for peer-review. Yuhang Wang and Emad Tajkhorshid. “Proton-
Coupled Substrate Transport in the BetP Membrane Transporter”
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FIGURE 5.1 The rocking-bundle alternating-access model for BetP which contains three major conformational
states: outward-facing (outward-facing), occluded (occluded) and inward-facing (inward-facing) stages. Note that
the conformational transition reaction between two stages is reversible.
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transporter that transport one betaine molecule into the cell while symporting two sodium ions (158). The
current paradigm of the functional mechanism for BetP is known as the rocking-bundle model (159) as shown
in Fig.5.1, which is one type of the alternating-access model (160). In this model, the bundle domain stays
relatively rigid, while the rocking domain performs large scale conformational transitions. There are three
major stages in the transport cycle: inward-facing(inward-facing), occluded(occluded), and outward-
facing(outward-facing) stage. Each stage is characterized by the relative size of the inward/outward
facing lumen (substrate transport passage) inside the protein. The transition reaction between two stages is
reversible. By alternating between these three stages, there is a net flow of substrate from the periplasmic
side (in bacteria) to the cytoplasmic side of the cell. The energy source for this transport process is provided
through the concentration gradient of the co-substrate, for example sodium ions in BetP (158).
Recently it was found that with a single mutation G153D, BetP can also transport choline driven by
cross-membrane H2 gradient. This suggests that transport of different substrate and co-substrate must
have a large overlap in terms of the requirement in the overall protein architecture. It also points out
that certain residue locations are crucial for the function of membrane transporters, in this case, residue
153. Since this single residue no only changes the substrate specificity of the transporter, but also switches
the required co-substrate spices. Base on the fact that D153 has a titratable side-chain and the transport
energy source is proton gradient (pH gradient), one naturally speculates that the titration state of D153
must play an important role during the substrate transport. High resolution all-atom molecular dynamic
(MD) simulations are ideal tools for providing insight into protein-substrate interactions and the transport
mechanism. In this paper,we aim for addressing two transport mechanistic aspects of BetP-G153D: the role of
D153 in substrate transport, and protein global conformational changes in response to the presence/absence
of substrate.
We designed two sets of simulations to address effect of pH on substrate binding/release: one with neutral
D153 and the other with charged D153. Our results show that the substrate release event is ready to occur
as long as D153 is at its neutral state. However, the release event was not observed when D153 is at charged
state. This manifests a tight coupling of substrate-protein interaction and local pH environment. In addition,
we also observed significant global conformational changes in response to substrate release. There are three
major conformational states during the substrate transport process in BetP: outward-facing(outward-facing)
state, occluded(occluded) state and inward-facing(inward-facing) state. A total of 18 crystal structures of
BetP have been resolved (157, 161–164), which provides evidence and detailed descriptions of these states.
By comparing against these structures, our results show that the release of substrate triggers significant
conformational transitions from inward-facing state to occluded state. The rest of this paper will focus on
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two main aspects: substrate-protein interaction and global protein conformational transition
Methods
System preparation
The starting conformation of the simulation was based on the crystal structure of BetP-G153D mutant(162)
(PDB ID: 3P03). Two independent systems were built with difference on the protonation state of residue
Asp153. For both systems, a single BetP monomer (inward facing open state from chain C of 3P03)
was embedded in 1-Palmitoyl-2-oleoylphosphatidylcholine (POPC) membrane, solvated with TIP3P explicit
water and ionized with about 150 mM NaCl. The final system size was approximately 100 Å×100 Å× 90
Å. Residue Glu161 in BetP was assumed to be protonated based on pKa prediction result from PROPKA
(81, 165). System preparation was done using VMD (119).
Molecular dynamics
CHARMM 27 force field was used for protein atoms and ions (43) and POPC lipid atoms adopted CHARMM
36 force field parameters (88). The initial equilibration simulation was performed using NAMD (86) for
about 40 ns with rigid bonds for bonds involving hydrogens (using SETTLE (44)), with 2 fs time step and
periodic boundary condition. For non-bonded interactions, a cutoff distance of 12 Å was used along with
a switching function starting from 10 Å. Electrostatic interactions were calculated using the Particle Mesh
Ewald method (45–47). Temperature was kept constant at 310 K using the Langevin thermostat algorithm
(166), with Langevin damping coefficient 1/ps. Pressure was also maintained constant at 101,325 Pa with
isotropic Nosé-Hoover Langevin piston pressure control method (90, 91), with a barostat oscillation period
200 fs and damping time scale 50 fs. For each simulation system, the conjugated gradient method (with line
search algorithm) was used to perform energy minimization on lipid tails, then whole membrane, and finally
on BetP protein (about 1000 minimization steps each). After around 40 ns equilibration, the production
simulations for the two systems (with different protonation state for Asp153) were done using specialized
supercomputer Anton (167). The total length of simulations is about 2 µs for each system.
Free energy calculation
Umbrella sampling method was used to calculate the free energy of substrate release process. Two free
energies were calculated, one with D153 protonated and the other with D153 deprotonated. The reaction
coordinate is the distance between the center of geometry of the heavy atoms in D153 and the substrate
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choline. The initial states at each umbrella window were obtained by steered molecular dynamics (SMD)
(168). In the case of deprotonated D153, a total of 67 umbrella windows were used. The range of the
reaction coordinate is from 6 Å to 25 Å. The distance between neighboring windows is 0.25 Å, except for two
regions. To get better overlap in the samplings of two neighboring umbrella windows, a 0.2 Å interval was
used for the reaction coordinate between 9 Å and 10 Å, and a 0.1 Å interval was used for the region between
15 Å and 16.1 Å. Each umbrella window was simulated for 3.6 ns. In the case of protonated D153, a total
of 77 umbrella windows were used. The range of the reaction coordinate is from 6 Å to 25 Å. The interval
between neighboring umbrella windows is 0.25 Å, except for the two regions. The reaction coordinate region
between 9 Å and 9.2 Å has window interval 0.1 Å, while the region between 9.2 Å and 10 Å has interval
0.2 Å. Each umbrella window was simulated for 3.6 ns. The Weight Histogram Analysis Method (WHAM)
(169, 170) was used to analyze the distributions along the reaction coordinate and obtain the free energy.
Data analysis
Water number calculation
The number of water molecules within the cytoplasmic side lumen of BetP were calculated using VMD(119)
(text mode). The water selection region is defined as a sphere centered at the α-carbon of residue V381 with
a radius of 12 Å. The center and radius were chosen so as to best distinguish the bulk water and water in
the protein.
Root-Mean-Square-Deviation(RMSD) calculation
The Root-Mean-Square-Deviation(RMSD) calculations for helix TM3in were also done using VMD(119)
(text mode). Two reference structures were chosen: inward-facing state crystal (PDB: 3P03, chain C) and
occluded state crystal (PDB: 4AIN, chain B). Only the backbone α-carbon atoms were used for the RMSD
calculation. All trajectory fames were first aligned to the reference structure using the the backbone α-
carbon atoms of the 12 transmembrane helices (see Table 5.1 for definition), followed by the computation of
RMSD for TM3in(residue 138–150) and TM7(residue 300–324).
Microscopic pKa calculation
All microscopic pKa (µpKa) calculations were done using PROPKA (81) using crystal structures or confor-
mations sampled in the simulations. The conformations were extracted from the trajectories every 1.2 ns.
Atom and residue names were converted back to the standard protein data bank convention (e.g. residue




In the presence of proton gradient across the membrane, the only viable substrate for the BetP G153D mutant
is choline, not betaine (158). This fact clearly implies that D153 is the primary site for interaction with the
substrate. However, we still do not know how the protonation state of D153 changes at each stage of the
transporter cycle (Fig. 5.1), and which parts of the protein contribute most to the substrate binding/release.
Answers can be found by comparing two scenarios: a system with protonated D153 (neutral; denoted
BetP(o)) and another with deprotonated D153 (charged; denoted BetP(−)). From their differences, we
can deduce how the substrate choline interacts with D153 at two protonation states, as well as its effect on
the substrate binding/release process. We built these two systems and simulated each for more than two
microseconds (see Methods). The results of the two simulations showed great contrast in terms of substrate
releasing behavior. In the BetP(o) system, the substrate choline was released within ∼ 35 ns. However, in
the BetP(−) system, no substrate release event was observed in the entire simulation. To further confirm
the reproducibility of the results, we also performed another 10 short simulations of the BetP(o) system
with exactly the same starting conformation and setup but different distribution of initial velocity. No
repeats were attempted for the BetP(−) system, since the result of the above BetP(−) system shows that
the substrate release is well beyond microsecond time scale even if not impossible. Substrate release were
observed in nine out of the ten repeated simulations with various release time (9∼190 ns; Fig. 5.2). In the
only exceptional case (“BetP(o)2”), the substrate moved towards the interior of the protein (Fig. 5.2, panel
C inset) and the global protein conformation became close to that of the occluded state (Fig. 5.6, panel
B). This outlier case is due to the reversible nature of protein conformation transition. The cytoplasmic
side of the BetP lumen can hold 30-40 water molecules Fig. 5.4) which means D153 is well solvated. One
may expect the attractive interactions between the substrate choline and D153 (through hydrogen-bonding
or net-charge attraction force) to become very weak at the inward-facing state of BetP and may easily be
substituted by the water-D153 interactions. However, this is not supported by the simulations. As we will
see later that the protonation probability of D153 is very different from the behavior of an aspartic acid
residue in bulk water. This result support the view that protonation state of D153 alone dominates the
substrate binding/releasing of BetP. Global conformational changes in the whole protein is only a necessary
but not sufficient requirement for substrate transport
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FIGURE 5.2 Distance between the substrate choline (nitrogen atom) and BetP residue D153 (side-chain γ-carbon
atom) for both long and short repeated simulations: BetP(o) and BetP(−) (panel A); repeated BetP(o) systems
(panel B). The block-averaged distances are shown as dark solid lines, while the raw data is show in lighter color. A
representative snapshot of the the system at different substrate release stages is show in panel C. The inset of panel
C shows the location of choline in the repeated simulation of the “BetP(o) 2” system (upper left), in comparison to
the location of choline in the crystal (PDB: 3P03, chain C) structure (cyan, lower right).
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Another detail revealed by the simulation is that the substrate binding is a highly dynamic process
reflected by the large variations in the interaction distances between the substrate and D153 (3∼15 Å; Fig.
5.2). The reversibility of the binding/release reaction at small scale is clearly captured by the 3rd and 7th
repeated simulation of the BetP(o) system (BetP(o) 3 & BetP(o) 7) (Fig. 5.2, panel B). In this case, the
substrate moved 15 Å away from D153, moved back, then moved away again and eventually left the protein.
The constant binding and (incomplete)unbinding events were also observed in the BetP(−) system. The
implication is that substrate binding/unbinding in BetP is a very fast (nanosecond time scale) process and
the substrate transport in BetP is not limited by substrate diffusion but the protonation state of the binding
site and the global protein conformational state.
Besides D153, other residues in BetP also contribute to the substrate binding process. We have identified
three other residues that may be important for substrate binding/transport: A148, G149 and Y197, via
hydrogen bonds between the substrate and the residue’s backbone carbonyl group or side chain hydroxyl
group. Y197 has strong interaction with the substrate with hydrogen bonding probability as high as 35%
(Fig. 5.3 histogram). A148 and G149 have weak but non-negligible hydrogen bonding contributions (<
10%). In comparison, the estimated contribution from hydrogen bonding between the substrate choline and
D153 is about 30% (Fig. 5.2 histogram). These three residues (A148, G149 and Y197) could be the main
contributors to the binding of substrate betaine in wild type BetP (no D153).
Conformational transition from inward-facing to occluded state
To understand how the membrane transporter function, it is best to first find out what are the sequence
of events occurring during the transporter functional cycle. The three-stage conformational transition (Fig.
5.1) has long be the paradigm for the functional mechanism of secondary membrane transporters including
BetP. However, the details of these conformational transitions are very sketchy at this moment due to
limitations of the current experimental techniques for measuring protein dynamics. One of the goals of this
simulation study to uncover some parts of the conformational transition events. Thanks to the large time
scale sampling of our simulations, some details for inward-facing to occluded stage transition were revealed.
After the release of the substrate choline, the conformation of the BetP(o) system gradually shifted from
inward-facing state to occluded state. This is indicated by the drop in the number of water molecules
accommodated in the BetP cytoplasmic side lumen (from 30 to 15 approximately) (Fig. 5.4). In contrast,
the number of water molecules in the BetP(−) system first dropped (around 20) and gradually increased
back (between 30 and 40). This means the releasing of the substrate can readily trigger the conformational
transitions. From another point of view, the substrate can stabilize the inward-facing conformation.
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FIGURE 5.3 Interaction distances between substrate choline and A148, G149 and Y197. The distance was calcu-
lated using the oxygen in choline and the backbone carbonyl oxygen (A148, G149), or the side chain oxygen (Y197).
A normalized histogram of the distribution of the interaction distances are show on the right side of each panel. For
BetP(o) simulation, the time axis is shown in blue and at a different scale. Two longest repeated BetP(o) simulations
(“BetP(o) 2” and “BetP(o) 7”) were chosen as representative samples. For “BetP(o) 7”, data was truncated at 190
ns (beyond which the substrate left the protein). Representative snapshots (from the BetP(−) trajectory) for each
interactions are shown in the third column.
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FIGURE 5.4 The number of water molecules insides the cytoplasmic side of the BetP lumen for both the long and
short simulations: BetP(o) and BetP(−) (panel A); repeated BetP(o) systems (panel B). The spherical selection
region for water inside the BetP inward-facing lumen is shown in panel C. The center was chosen to the α-carbon
of V381 (yellow sphere) and the selection radius was set to 12 Å, so that the selection sphere can enclose all lumen
water molecules(blue spheres). The protein is colored by the residue types: hydrophobic(white), hydrophilic(green),
negatively charged(red), and positively charged(blue).
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The global protein conformation is characterized by the relative orientation of these helices. BetP has 12
transmembrane helices (see Table5.1 for definition). Root-mean-square-deviation (RMSD) of the coordinates
of the backbone α-carbon atoms of these transmembrane helices were used as a metric to determine whether
each transmembrane helix is closer to the inward-facing state or the occluded state conformation. Out of all
12 transmembrane helices, we found TM3in showed the most significant changes and clearly moved towards
the occluded state (Fig. 5.5, panel A & B), which can be as close as 1 Å to the occluded state in terms of
RMSD. TM7 also moved closer to the occluded state, although the magnitude of change is not as pronounced
as TM3in (Fig. 5.5, panel C & D).
A detailed transport cycle scheme of BetP has been previously proposed by Ziegler group based on
different conformational states captured by crystallography (157, 161, 162). In particular,the cytoplasmic
gate (cytoplasmic side) is mainly controlled by TM3in (5 Å displacement and 18
◦ titling) and TM7. The
gating behavior of TM3in and TM7 was indeed captured in the simulation (Fig. 5.5). However, we note that
the motion of TM7 may not be the rate-limiting factor for conformational transition, since the RMSD of
TM7 with respect to the occluded crystal (PDB: 4AIN, chain B) in the BetP(−) system can also reach a level
as close as ∼1 Å (Fig. 5.5). Similar observation is also found in the 3rd repeated BetP(o) system (Fig. 5.6).
In our view, the cytoplasmic gate consists of TM3in alone. Furthermore, the extreme plasticity of TM3in
was proposed to be due to the binding/unbinding of the Na+ induced backbone dihedral angle change (157).
In the light of the simulation results of this study, it seems to be more reasonable to attribute the plasticity
of TM3in to the transmembrane helix architecture itself, i.e., the flexible loop region connecting TM3in an
TM3out. We also propose that the major cause for the shift in conformation of TM3in is the helix-substrate
interaction, primarily through residue A148, G149 and Y197.
Another question is how the global conformational transition is related to the physical chemical nature
of the substrate. CaiT antiporter shares the same structural core as BetP (171). A recent study of the
CaiT antiporter showed that the cation requirement for transport in LeuT transporter family is due to the
necessity of a positive charge to stabilize the TM3in helix (172). In particular, Kalyail et. al. (172) proposed
that the coordination TM3in, TM7 and TM10 by a cation at the Na2 site is essential for the transport cycle.
Our results have shown that the substrate and the binding site (D153) has a large interaction range (3–16
Å) (Fig. 5.2). Static coordination centered around the substrate is very unlikely. The inward-facing state
conformation should not be viewed like a tent that is rigidly supported by the poles. Instead, we argue that
the existence of the substrate inside the cytoplasmic lumen is enough to provide the necessary repulsion
force to prevent the retraction of cytoplasmic gate TM3in. This is more like a pocket filled with coins. Once
the coins are gone, the pocket mostly likely will become flat. The physical chemical nature of the substrate
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provides attraction force necessary to stay inside the cytoplasmic lumen (approximately) and the strength
of the attraction force changes depending on the protonation state of the substrate binding site (D153).
FIGURE 5.5 RMSD for cytoplasmic side transmembrane helix TM3in (panel A and B) and transmembrane helix
TM7 (panel C and D), with respect to the inward-facing stage crystal structure (3P03, chain C) or occluded stage
crystal structure (4AIN, chain B). Panel E shows a comparison between the last trajectory frame from the BetP(o)
simulation (white) and the crystal structures, i.e. inward-facing state (blue) and occluded state (yellow).
















Substrate binding free energy coupled to protonation of D153
To further quantify the effect of protonation at the binding-site residue D153, we performed free energy
calculations of the substrate release process with different protonation states at D153 with BetP at the
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FIGURE 5.6 RMSD for cytoplasmic side transmembrane helix TM3in (panel A and B) and transmembrane helix
TM7 (panel C and D) for repeated BetP(o) simulations, with respect to the inward-facing stage crystal structure
(3P03, chain C) or occluded stage crystal structure (4AIN, chain B).
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inward-facing open state. The results (Fig. 5.7) indicate that with D153 protonated, the substrate release is
a favorable event, with a gain of 2.5 kcal/mol. In contrast, the substrate release is unfavorable when D153
is deprotonated, white a cost of 11.9 kcal/mol. This indicates that the substrate release event is strong
influenced by the protonation state of the substrate binding site. To further investigate the effect of protein
conformation on the substrate release, we also performed an additional free energy simulation of BetP with
D153 deprotonated starting from the more open conformation sampled by the MD simulation. Interestingly,
the free energy barrier dropped to ∼5 kcal/mol (Fig. 5.7 green). The difference between the free energy of
substrate release with protonated D153 and deprotonated D153 is 14.4 kcal/mol with crystal conformation.
Assuming a Boltzmann distribution of states, this 14.4 kcal/mol free energy difference corresponds to a
probability ratio of 1.8×106, suggesting a strong effect of protonation state of D153 on the substrate release.
This free energy difference dropped to 7.5 kcal/mol, which corresponds to a probability ratio of 1.8×103.
This implies that the conformational state of the transporter also contributes significantly to the substrate
release process.






















FIGURE 5.7 Comparison of substrate binding free energy with the binding site residue D153 protonated (BetP(o))
or deprotonated (BetP(−)) with BetP at the inward-facing open state staring from the crystal structure (blue and
red), or staring from the more open conformation sampled by the microsecond-scale simulation of BetP with D153
deprotonated (green).
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Microscopic pKa of D153 upon conformational transition
pKa is commonly viewed as an alternative to the equilibrium constant of the acid dissociation reaction which
can only be expressed as one single number since it describes the equilibrium state within a large (almost
infinite) time scale. Another view of pKa is that it represents the probability of gaining a proton (the higher
pKa, the higher probability to be protonated). From this perspective, it is often very useful to look at the
protonation reaction at sub-microsecond scale, where we can track the changing of the target chemical group’s
probability of being protonated. Therefore it is natural to define a concept of microscopic pKa (µpKa) as
the protonation likelihood for a given physical chemical environment surrounding the target chemical group.
In fact this the foundation behind one of the most popular pKa calculation engines: PROPKA (81).
As mentioned earlier, the protonation state of D153 is the determining factor for substrate release. To
gain more insight into the shift of protonation state distribution of D153 upon conformational transition from
inward-facing state to occluded state, we calculated the µpKaof D153 using the conformations (substrate
included) sampled by the simulations (Fig. 5.8, panel A1). Upon transition to the occluded state, the average
µpKa of D153 from the BetP(o) system increased from 6.5 to a level between 8 and 9. Similar behavior was
also observed for the 2nd repeated BetP(o) simulation (Fig. 5.8, panel A2). In contrast, the average µpKa
of D153 in the BetP(−) system stayed around 6.5. One may notice that there was sudden drop of µpKa
near 1000 ns in the BetP(o) system (Fig. 5.8, panel A1). This was caused by the simultaneous formation
of two hydrogen bonds between S253–D153 and W373–D153 (Fig. 5.8, panel B1, C1 & D). Although the
snapshot shown in panel D of Fig. 5.8 seems to suggest the favoring of protonated state of D153, the actual
PROPKA results indicated otherwise. This result is still intuitive considering the possibility of another
double hydrogen bond configuration with deprotonated D153 and the S253’s proton hydrogen-bonded to
D153’s side chain oxygen.
TABLE 5.2 µpKaof D153 from different crystals at different conformational state












This double-hydrogen-bond configuration was not observed in the simulation of the BetP(−) system or
other BetP(o) systems. In addition, we also calculated the µpKa of D153 in different crystals (Table 5.2).
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FIGURE 5.8 Row 1: changes in microscopic pKa (µpKa) of D153 (calculated using PROPKA (81)) for long MD
simulations (A1) and shorter repeated simulations (A2). The substrate is included in the calculation. The sudden
drop in µpKa in BetP(o) simulation was due to the formation of double-hydrogen bond between the substrate and
residue W373 and S253 at round 1000 ns (gray highlighted region). The substrate choline is included in the pKa
calculation. Row 2 (B1 & B2): distance between side chain oxygens of D153 and S253. Row 3 (C1 & C2): distance
between side chain oxygens of D153 and the side chain nitrogen of W373.
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FIGURE 5.9 Diagram of proposed change of µpKa of D153 during the transport cycle, based on PROPKA results
calculated using MD trajectory and crystal structures. The estimated µpKa values are labeled in white.
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Combing all these µpKa results, a schematic diagram of the change of protonation ability of D153 at each
conformational state of BetP is show in Fig. 5.9. In the experimental pH condition from reference (162) for
BetP reconstituted in E. coli lipid proteoliposomes, the outside (equivalent to periplasm) pH is 5.5 and the
inside (equivalent to cytoplasm) pH is 7.5. Under this pH gradient, D153 can transport a proton even in the
presence of a bound substrate(choline) based the µpKa diagram (Fig. 5.9) which really explains the proton
gradient driven substrate transport in BetP. However, one may suspect that one proton will be transported
back to the outside (or periplasmic side) since the µpKa of D153 increases at the intermediate occluded
state. Our hypothesis is that due to the existence of double hydrogen bond configuration (Fig. 5.8), the long
time average of µpKa of D153 may be lower than the inside pH (e.g., 7.5) and therefore the inside-to-outside
transport of a proton may be unlikely.
Conclusion
In this study, we have shown that the protonation state of the central binding site residue D153 has a strong
effect on BetP’s binding affinity to its the substrate choline. When the residue D153 is protonated, the
substrate binding affinity is low. Within 2 µs, the conformational state of BetP spontaneously transitioned
from the inward-facing open state to the occluded state. In contrast, when the residue D153 is deprotonated,
BetP’s binding affinity to the substrate becomes significantly higher and no substrate release event was
observed within the 2 µs of simulation. The conformational state of BetP remained at the inward-facing
open state. Theses results indicated that the releasing of the substrate is a significant event that can trigger
conformational transitions in a transporter such as BetP. Moreover, this study also provides evidence that
changing protonation state alone can trigger substrate release.
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Chapter 6




Detergents play a key role in the scientific research of membrane proteins (173) as well as industrial appli-
cations (174, 175). In membrane protein studies, almost all proteins have to go through a protein-detergent
complex state (176), which is often termed “proteomicelle” (177–181). Detergents are crucial for extracting
and in vitro stabilizing membrane proteins (182–185), which are the key steps for structural (186–190) and
functional studies (191–193) of these proteins. The molecular structure of many membrane proteins have
been determined at the detergent-solubilized state, such as the human erythrocyte anion-exchanger (194),
the heat- and capsaicin-activated ion channel TRPV1 (195), the ligand-gated purinergic receptor P2X3 re-
ceptor (196), the strychnine-sensitive glycine receptor (GlyR) (111), and the glutamate-activated AMPA
receptor (4, 197). Although recent development of nanodisc based methods (198–200) helps eliminating
some uses of detergents in membrane protein research (201–204), these methods have their own limitations
(205–207). We expect detergents will continue to be used in membrane protein researches.
Protein-detergent interaction is an important research topic, because detergents can strongly affect the
structure, function and packing of membrane proteins in proteomicelle forms (208). Although some mem-
brane proteins in detergent micelles can still preserve their secondary and tertiary structures (209–211),
many other membrane proteins are strongly affected by the choice and concentration of detergents. In some
early studies of bacteriorhodopsin, trimers were formed in lipid cubic phase (212), but only monomers were
observed when crystallized in the lipid/detergent bicelle environment (213). In the crystallization of lac-
tose permease, changing the detergent-lipid ratio resulted in different crystal forms of disparate resolutions:
hexagonal (5 Å), orthorhombic (3 Å), or tetragonal (2.6 Å) (214). In an experimental study of the integral
membrane protein diacylglycerol kinase (DAGK) using the UV-detected coupled assay system and NMR, 9
out of 10 chosen detergents impaired the protein’s catalytic activity, while adding lipids recovered the activ-
ity loss in most cases (215). A recent study showed that the stability of glycophorin A transmembrane helix
1This chapter will be submitted for peer-review soon. Yuhang Wang and Emad Tajkhorshid. “SimShape: a Method for
Proteomicelle Modeling”
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dimer in lysophosphatidylcholine micelle is linearly proportional to the detergent aggregation number, using
Föster resonance energy transfer (FRET), circular dichroism (CD) spectroscopies, as well as static-light-
scattering (SLS) and dynamic-light-scattering (DLS) experiments (208). Moreover, the protein denaturing
effect of detergent like sodium dodecyl sulfate (SDS) and the refolding effect of nonionic detergents like dode-
cyl maltoside (DDM) has been recently quantified for four proteins: bovine serum albumin, α-lactalbumin,
lysozyme, and β-lactoglobulin, using small-angle x-ray scattering and near-UV/far-UV circular dichroism
(CD) (175).
A molecular level explanation for the effects of detergents on membrane proteins is of great value to
the design of membrane protein research (176, 216). There are many experimental approaches to study
proteomicelles at the molecular level. One of the most effective ways is to apply structure determination
methods to study specific effects of detergent-protein interactions. The close interactions between proteins
and detergents have been captured in many previous structural studies using X-ray crystallography (217–
219) and contrast-matched neutron crystallography (220, 221). However, atomistic details of the structure
and dynamics of the detergents are often limited by the resolution and time scale of these techniques.
Computational methods are well suited for filling this gap and have already provided insights for various
systems, such as the outer membrane protein OmpA (222), the LeuT transporter (178, 181, 223, 224), the
G-protein coupled receptor (GPCR) (225), and the voltage-dependent potassium-selective channel KvAP
(226). Using all-atom (227, 228) or coarse-grained molecular dynamics simulations (229, 230), the molecular
level details of many pure micelles and protein-detergent micelles have be extensively characterized. Recent
computational studies showed that detergent molecules can compete with substrate binding at the S2 site in
LeuT transporter depending the detergent species and concentration (178, 181). It has also been reported
that different short chain nonionic detergents have different destabilization effects on G-protein-coupled
receptor A2AR (225).
Computational study of the proteomicelle usually requires building an initial model which is a nontrivial
task. Although de novo proteomicelle assembly can be used as an alternative approach (228, 229, 231), study
on the effects of detergent aggregation number (208) and detergent composition (175) requires a precisely
generated initial proteomicelle model (178, 181). Currently there are several methods for building such
models. In one method (232), pseudo-atoms were used as reference positions for placing detergent molecules
randomly drawn from a library of conformers. Each detergent is oriented to ensure the tail group atoms are
within the micelle hydrophobic core. In an alternative method (225), detergents were geometrically arranged
around the hydrophobic belt region of the target protein. In some other studies (178, 181), detergents were
initially placed on a sphere larger than the protein, and with head groups pointing outwards. Then the
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detergents are gradually moved towards the protein while periodically performing energy minimization to
remove steric clashes. Although all these methods work well in some cases, there are limitations. In the
first two methods, the maximum number of detergents can be placed around the protein is limited by the
constraints of avoiding steric clashes, and may not be able reach the user defined detergent aggregation
numbers. Another limitation of the geometric methods is the ring-piercing between the detergents (e.g.,
DDM) and protein residues with ring structures (e.g., Phe). The third method requires manual adjustments
for different types of proteins, and there are usually gaps left between the protein and the detergents in the
final configuration. A follow-up simulation is usually required for completing the proteomicelle assembly
process (178, 181).
A reproducible computational research on proteomicelles demands a methodology that can assemble
proteomicelles with characteristics of a well equilibrated one and be automatically adaptable to proteins
of different sizes and shapes. To address these challenges, we propose an alternative methodology for
building proteomicelles named “SimShape”, which stands for “Simulated Shape”. Its main feature is the
incorporation of dynamics into the building process rather than solely relying on geometric placement with
or without energy minimization. By design, the generated proteomicelles are free of steric clashes or ring
piercings. As a result and as a distinct feature, users can easily adjust the number of detergent molecules
in the proteomicelle without trial and error. More realistic detergent packing can also be achieved without
the need for any library of detergent conformers which enables assembling proteomicelles with any novel
detergent molecules.
Methods
The general idea behind the SimShape method is to accelerate the micelle aggregation process by using
external forces to direct detergent molecules to pack around the target protein which can be achieved at
the picosecond time scale. The SimShape method uses grid steered molecular dynamics (GSMD) (84) and a
customized grid potential to achieve accelerated detergent aggregation around the target protein. We vali-
dated our method by comparing the SimShape generated proteomicelle to a benchmark trajectory obtained
by performing an unbiased all-atom molecular dynamics (MD) simulation (∼0.5 µs) of the proteomicelle for-
mation process in explicit solvent. As an illustrative example, we chose human glucose transporter GLUT1
(233) and detergent n-Dodecyl-β-D-Maltopyranoside (DDM) (Fig. 6.2 d) for detailed characterization of
the quality of the proteomicelle built by SimShape. Then, three other membrane proteins of different shapes
and sizes were chosen as targets to demonstrate the general applicability of the SimShape method.
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FIGURE 6.1 (a) and (b): side view and top view of the initial placement of detergent molecules (DDM) on a
toroidal surface. The protein (GLUT1) is shown in while. (c) and (d): side view and top view of representative
isosurfaces of two toroidal grid-based potentials (gray) as well as the prism-shaped grid-based potential. As a
comparison, the 25% occupancy map of atoms from all detergent molecules from the benchmark simulation is shown
in cyan.
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FIGURE 6.2 (a) and (b): side view and top view of the potential value maps corresponding to the outer toroidal
grid-based potential. (c): side view of the potential value map of the prism-shaped grid-based potential. (d):
chemical structure of DDM prepared by ChemAxon-MarvinSketch (234). The head group oxygen atom (1O6) and
three tail group carbon atoms (C1, C6, and C12) are highlighted as large circles.
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SimShape protocol
There are three key steps in the SimShape protocol: initial detergent placement, construction of attractive
grid-based potentials, and GSMD (84) simulation configuration. The first two steps were automated using an
in-house software package (available at https://github.com/yuhangwang/SimShape) written in the Julia
programming language (235). The last step can be performed using NAMD (86).
Initial detergent placement
detergent molecules (DDM) were placed on the outer surface of a torus with a major radius of 80 Å and a
minor radius of 15 Å (Fig. 6.1 a, b) using the Fibonacci Spiral algorithm. The size of the major radius was
chosen to allow enough space for placing the detergent molecules needed to form the target proteomicelle.
The minor radius was chosen based on the height of hydrophobic belt region of the target membrane protein
which is usually around 30 Å. The center of the detergent molecules along the z axis was at ∼5 Å. Note
that SimShape currently doesn’t support automatic placement of membrane proteins. External application
services such as OPM database and PPM server (236–238) can usually generate very reasonable initial guess.
The initial location and orientation of GLUT1 was determined using the PPM server. The choice of z-center
of detergents for GLUT1 was based past experience of simulating the GLUT1-membrane systems.
Construction of attractive grid-based potentials
three grid-based potentials (Fig. 6.1 c-d, 6.2 a-c) were used to provide attractive forces to the detergent
molecules for accelerated aggregation: two have the shape of a double-elliptic torus and one has the shape
a prism. The DDM head group heavy atoms (excluding hydroxyl/hydroxymethyl groups) were coupled to
the outer toroidal grid-based potential, while the tail group heavy atoms were coupled to the inner toroidal
grid-based potential. In addition, the last tail group carbon atoms (C12) were coupled to the prism-shaped
potential to prevent detergent tail groups from moving too far away from the protein hydrophobic belt
surface. Furthermore, to gain more flexible control over the detergent orientations during the assembly
process, the terminal tail carbon atoms (C12) also had an additional coupling to the inner toroidal grid-
based potential with an independent coupling strength scaling factor. The design of the toroidal shape
of the grid potential was inspired by experimental results using contrast-matched neutron crystallography
(220, 221). The size of the toroidal potential was based on the size of the hydrophobic belt region of the
target protein. For GLUT1, the standard deviation of the protein XY coordinates along the first and second
principal axes on the XY plane was 12.8 Å and 8.3 Å, respectively. For the outer torus, the eccentricity of
the major ellipse was
√
5/3, based on the ratio of these two standard deviations. The major ellipse had a
76
semimajor axis of 30 Å and a semiminor axis of 20 Å, which were obtained by scaling up the two standard
deviations by an empirical factor of ∼2.3. The minor ellipse had a semimajor axis of 30 Å and a semiminor
axis of 20 Å (elongated along the Z axis), which was based on the detergent length and the height of the
protein hydrophobic belt region. The size of the major ellipse of the inner torus was the same as that of
the out torus. Its minor ellipse had a semimajor axis of 18 Å and a semiminor axis of 8 Å. The interior of
the torus has zero potential energy and linearly increase outward from the toroidal surface at the rate of 1
kcal/mol/Å (Fig. 6.2 a, b). The actual effect of the grid-based potential was scaled by a coupling constant
(see section GSMD simulation configuration). The third grid-based potential has the shape of a simple
rectangular prism (infinite along the x-y plane, and with a height of 30 Å along the Z axis). Its potential
values were zero within the hydrophobic belt region (30 Å tall) and linearly increased when moving away
from the boundary surfaces (Fig. 6.2 c). All three grid-based potentials were centered around the center of
the protein (x = 1.4 Å, y = 0.5 Å) on the XY plane and centered at +5 Å along the Z axis due to inaccuracy
of membrane protein placement of the PPM server.
GSMD simulation configuration
1000 steps of energy minimization and 100 ps MD with implicit solvent were performed on the assembled
initial system with the heavy atoms from DDM coupled to the grid-based potential. A scaling factor for
the force generated by the grid-based potential (coupling constant) was used to fine-tune the magnitude of
external forces. The coupling constant between the first grid and the tail group heavy atoms (12 atoms
per DDM) was 0.14, and it was 0.18 between the second grid and the head group heavy atoms (excluding
hydroxyl/hydroxymethyl groups, 14 atoms per DDM). The last tail group carbon atoms (C12) were coupled
to both the first grid (coupling constant 0.1) and the third grid (coupling constant 0.14). Note that these
parameters were optimized for generating realistic proteomicelles for the GLUT1-DDM system. In practice,
we recommend the users to start out with these parameters and modify them when necessary. The balance
between the pulling force on the head and tail group atoms is key to the proteomicelle assembly. If the force
on the head groups is too weak, the micelle will become too flat, while strong force can cause head groups
to be buried inside the micelle. In addition, the C12 carbon atoms can strongly influence the orientation
of the detergent molecules. From our experience, coupling to two grid-based potentials as mentioned above
is necessary. Protein backbone heavy atoms were harmonically restrained to their initial positions (k = 50
kcal/mol/Å2) to prevent drifting.
The GSMD in SimShape was conducted in an implicit solvent system. The Generalized Born implicit
solvent model (77, 128) was used, with a Born radius cutoff of 14 Å, a solvent dielectric constant of 80,
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a surface tension coefficient of 0.005 kcal/mol/Å2, and 150 mM ionic strength. A switching function was
applied to non-bonded interactions which took effect at 15 Å. It gradually decreased to zero at the non-
bonded interaction cutoff distance (16 Å). A 2-fs time step was used. Short range non-bonded interactions
were calculated every step, and long-range electrostatic interactions were calculated every other step. A
Langevin thermostat (48) was used to maintain an average temperature of 310 K, and a Langevin damping
coefficient of 1/ps was used. NAMD 2.12 (86) was used to perform the computation with CHARMM36 force
field parameters for both proteins (120) and detergents (239).
Changing aggregation number and application to other proteins
To demonstrate the applicability of the SimShape method for building proteomicelles of different sizes, six
different detergent aggregation numbers were tested for the GLUT1-DDM system: 160, 180, 200, 220, 240,
and 260, using the same protocol as described earlier (with the same grid potentials). In addition, three other
proteins were chosen to test the robustness of the SimShape method, including the pentameric-ligand gated
ion channel from Erwinia chrysanthemi (ELIC) (240), the multidrug resistance protein P-glycoprotein (Pgp)
(241), and tetrameric water channel aquaporin 1 (AQP1) (242), with 340, 240, and 450 DDM detergents
respectively. The initial structure of ELIC was prepared using the crystal structure (PDB ID: 3rqu). For
Pgp and AQP1, the initial structures were taken from previous equilibrium MD trajectories (3 ns and 300
ns respectively). The detergent aggregation number was chosen based on the surface area of the protein
hydrophobic belt region relative to GLUT1. The general shape of the grid-based potentials for these three
proteins was analogous to that of the GLUT1-DDM system (Fig. 6.1 b, d). For ELIC and AQP1, the
major ellipse of the outer tori had major radii of 32 Å and 38 Å, respectively. For Pgp, the major ellipse
of the outer torus had a semimajor axis of 33 Å and a semiminor axis of 22 Å. The major ellipses of the
inner tori of all three cases shared the same parameters as those of the outer tori. The parameters for the
minor ellipses of both the outer and inner tori in these three cases were the same as those in the case of
GLUT1-DDM system, because all four proteins shared the same height of the hydrophobic belt region and
the same detergent (DDM) was used. If a different detergent is needed, we recommend the users to start
the grid potential optimization process by scaling the parameters of the minor ellipses based on the ratio of
the length between the new detergent and DDM. To evaluate the stability of the proteomicelles assembled
by SimShape, a 30 ns equilibrium MD simulation was performed on each assembly in explicit solvent, using
the same protocol as the benchmark simulation.
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Fibonacci Spiral algorithm
The following function uses the Fibonacci Spiral algorithm to generate coordinates for N points located on
the surface of a torus. N is the total number of points (center of mass of each detergent molecule) to be
placed. r0 is the major radius of the torus. a and b are the semimajor axis and semiminor axis respectively
of the cross-section ellipse. ∆θ is the golden angle (≈ 137.508◦). ∆z is the decrement along the z axis. z0
is the initial z coordinate.
Algorithm 1 The Fibonacci Spiral algorithm
1: function fibonacci(N, r0, a, b)
2: ∆θ = π · (3−
√
5)
3: ∆z = 2bN
4: z0 = b− ∆z2
5: function coordinates(i)
6: r = r0 + a ·
√
1− ( zb )2
7: θ = i ·∆θ
8: return (r · cos θ, r · sin θ, z0 − i ·∆z)
9: end
10: return {coordinates(i) | 1 ≤ i ≤ N}
11: end
Benchmark preparation
A self-assembly simulation was performed to set benchmarks for various properties of the GLUT1-DDM
system with 200 detergent molecules. To shorten the initial diffusion-limited aggregation period, detergents
were initially arranged on a sphere and gradually brought from 80 Å to 45 Å away from the center of the
protein over 100 ps using the SimShape method. The last frame was used as the starting configuration for
the benchmark simulation. The system was solvated and ionized with 150 mM NaCl. The final system size
was 170 Å×170 Å×170 Å and contained 465,210 atoms.
Benchmark simulation parameters
The benchmark system was first energy-minimized for 500 steps and then simulated using equilibrium MD
for ∼540 ns. During the first 1.5 ns, the backbone heavy atoms of the protein were restrained with spring
constant decreased from 1 kcal/mol/Å2 to zero. A 2-fs time step was used. Electrostatic interactions were
calculated using the Particle-Mesh Ewald algorithm (92, 93) with 1 Å grid spacing. A switching function was
applied to all nonbonded interactions. It took effect at 10 Å and decreased to zero at 12 Å (the cutoff distance
for both electrostatics and van der Waals interactions). Short range non-bonded interactions were calculated
every step, and long range electrostatic interactions were calculated every other step. Isothermal-isobaric
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FIGURE 6.3 (a) and (c): side view and top view of the selected hydrophobic residues. (b) and (d): side view and
top view of the selected hydrophilic residues.
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ensemble (NPT) was applied to the system with average temperature 310 K and average pressure 101,325
Pa. The Langevin thermostat (48) was used with a damping coefficient of 1/ps. The Nosé-Hoover-Langevin
pressure control algorithm (90, 91) was used for maintaining the system pressure. The barostat oscillation
time scale was set to 100 fs, and the barostat damping time scale was set to 50 fs. The conjugated gradient
(51) with line-searching algorithm (52) was used for energy minimization. NAMD 2.12 (86) was used to
perform the computation with CHARMM36 force field parameters for both proteins (120) and detergents
(239).
Surface hydrophobic/hydrophilic residue selection
Surface hydrophobic residues of GLUT1 within the hydrophobic belt region were selected by the following
steps. First, solvent accessible surface area (SASA) of each residue was calculated. Then we select residues
with SASA greater than 20 Å2, z coordinates between 6 Å and 12 Å (hydrophobic belt region), and distance
to the center of the protein on the x-y plane greater than 12 Å (Fig. 6.3 a, c). Hydrophilic residues were
selected according to the same criteria, except that the z coordinates were either less than 6 Å or greater
than 12 Å (Fig. 6.3 b, d).
Results and Discussion
We first demonstrate the SimShape method by assembling a proteomicelle with the commonly used x-ray
crystallography detergent DDM (188) and human glucose transporter protein GLUT1 (233). To demonstrate
the major strength of the SimShape method, i.e., versatility, we also explored different detergent aggregation
numbers (160, 180, 200, 220, 240, and 260). In addition, we also tested three other proteins of different sizes
and shapes with very few changes to the geometric parameters of the grid potential.
Proteomicelle size
To quantify the size of the SimShape proteomicelle, we measured the radius of gyration of four different
types of atoms in the DDM detergent, i.e., three tail group carbon atoms (C1, C6, C12) and one head
group oxygen atom (1O6) (Fig. 6.2 d). It took around 40 ps before the SimShape GSMD simulation
converged, and the final radius of gyration values was very close to the benchmark values (Fig. 6.4), except
for the head group oxygen atom (1O6) which was ∼4 Å larger than the benchmark (Table 6.1). This is
likely caused by the lack of interactions between the detergent head groups and protein hydrophilic residues
(see the “Residue level interactions” section). Due to the short time duration of the SimShape simulation,
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these specific interactions are hard to capture and may vary for different proteins. In practice, the effect of
this discrepancy on the production simulation can be minimal if the SimShape-generated proteomicelle can
quickly relax to an equilibrium condition. To test this, we added water and ions (see Methods) to the system
and performed 30 ns equilibrium MD simulations, during which no detergent left the micelle. Moreover, the
radius of gyration values matched the benchmark very closely for all four types of atoms (within standard
deviation; see Table 6.1). Specifically, the head group atoms (1O6) came closer to the micelle core within 5 ns
and converged after 15 ns (Fig. 6.5). When comparing proteomicelles of different aggregation numbers, more
detergents yielded a larger radius of gyration for all four chosen types of atoms (especially C12) (Fig. 6.6).


























FIGURE 6.4 Changes in radius of gyration of four types of DDM atoms (C12, C6, C1 and 1O6) during the
SimShape GSMD simulation (SS, gray), relaxation MD simulation (SSr, blue, averaged over the last 15 ns), and
benchmark simulation (Benchmark, red, averaged over the last 240 ns). Note that the blue lines almost coincide
with the red lines.
Proteomicelle shape
The overall shape of the GLUT1-proteomicelle is elliptical based on the benchmark simulation. Here we
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FIGURE 6.5 Changes in DDM’s radius of gyration during the relaxation simulation (SSr, blue) with benchmark
values (Benchmark) shown in red. The averages (over the last 15 ns for SSr and the last 240 ns for Benchmark)
are shown as straight lines.
TABLE 6.1 Proteomicelle radius of gyration
C12 C6 C1 1O6
SimShape1 26.84 ± 0.11 30.93 ± 0.05 35.42 ± 0.07 43.68 ± 0.15
SimShape (relaxed)2 26.75 ± 0.33 29.80 ± 0.15 33.66 ± 0.11 39.42 ± 0.14
Benchmark3 26.57 ± 0.26 29.65 ± 0.19 33.57 ± 0.19 39.37 ± 0.25
1 last 20 ps 2 last 15 ns 3 last 240 ns
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FIGURE 6.6 Radius of gyration of GLUT1-DDM proteomicelles of different detergent aggregation numbers during
the SimShape GSMD simulations. As a reference, the average radius of gyration (over the last 15 ns) of the relaxation
simulations are shown as straight lines.




, where c2 = a2 − b2; a and b are the standard deviations of the X-Y
coordinates of the DDM detergents along the first and second principal directions (sorted by decreasing
eigenvalues) calculated by principal component analysis (PCA). All detergents were initially placed on a
circular torus (eccentricity 0). Within 20 ps, the eccentricity plateaued and reached an average value of
0.62 which is slightly higher than the benchmark value 0.49 ± 0.04. This is likely due to the approximation
made on the eccentricity of the shape of the grid potential which largely determines the final shape of the
proteomicelle. During the 30 ns relaxation MD simulation, the eccentricity dropped to 0.57 ± 0.02. When
comparing proteomicelles of different detergent aggregation numbers, the proteomicelle with 160 detergents
had the lowest eccentricity (0.52 ± 0.02) and the one with 240 detergents had the highest eccentricity (0.64
± 0.02), while the one with 260 detergents had about the same eccentricity (∼0.61) as the one with 220
detergents (Fig. 6.8). This indicates that aggregation number may not correlate with proteomicelle shape.
Detergent orientation
The orientations of the detergent molecules around the protein in the benchmark simulation followed closely
to the surface of a toroidal shape as measured by the detergent occupancy map (Fig. 6.9). The longitudinal
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FIGURE 6.7 Change in the eccentricity of the detergent shell of the GLUT1-DDM proteomicelle during the
SimShape GSMD (SS, left) and the relaxation MD (SSr, right) simulations, with benchmark (Benchmark) values
shown in red. The average values (over the last 20 ps for SS, last 15 ns for SSr, and the entire trajectory for
Benchmark) are shown as straight lines and the standard deviations are shown as shaded areas.
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FIGURE 6.8 Eccentricity of the detergent shell of the GLUT1-DDM proteomicelles with different detergent ag-
gregation number in the SimShape GSMD simulation (left) and the relaxation simulation (right). The raw data are
shown in translucent colors and running averages are shown as solid curves. The average values over the last 15 ns
of the relaxation simulations are shown as straight lines.
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axis of the protein was initially aligned to the z axis. The detergent head groups near the pole regions were
oriented more parallel to the z axis and became perpendicular to the z axis near the equatorial region (Fig.
6.9). In the final configuration of the SimShape proteomicelle, the overall distribution of DDM orientations
were comparable to that of the benchmark, and further relaxation brought more improvements (Fig. 6.9).
To quantify the detergent orientations, we used the angle between longitudinal axis (third principal axis) of
each detergent and the z axis (also the protein longitudinal axis). The distribution of orientation angles of the
detergent molecules in the benchmark simulations spread across the entire range of possible angles except for
the extremely small or large angles (Fig. 6.10). On the other hand, detergents in the SimShape proteomicelle
were mostly oriented between 60° and 120° away from the z-axis. This mismatch almost entirely diminished
after 30 ns of equilibrium simulation (Fig. 6.10). Similar distributions were also observed in proteomicelles
with different number of detergents (Fig. 6.11). This result indicates that the same initial placement and
same grid potentials yield predictable distributions of detergent orientations.
Z-coordinate distribution of detergents
Membrane proteins usually have a hydrophobic belt region which aligns with the membrane hydrophobic
core. Although SimShape protocol isn’t able to determine the hydrophobic belt region of a protein, existing
tools like the OPM database and PPM server (238) are usually sufficient to obtain a good estimate. To
quantify the dispersion of detergent tails along the z axis, we measured the distribution of the z-coordinates
of four types of atoms from DDM, i.e., three tail group carbon atoms (C1, C6, and C12) and one head
group oxygen atom (1O6). The distributions of the tail group atoms along the z axis were very close to the
benchmark, but the head group atoms had a slightly narrower distribution (Fig. 6.12). Within 30 ns of
the relaxation simulation, all four distributions came to match to the benchmark closely (Fig. 6.12). The
z-coordinate distributions of these four types of atoms from proteomicelles of different aggregation numbers
matched well with each other, which indicates the robustness of the confinement force originating from the
imposed grid potentials (same across all proteomicelles) (Fig. 6.13).
Hydrophobic surface coverage
To measure the coverage of the surface area at the hydrophobic belt region, we measured the solvent ac-
cessible surface area (SASA) of the surface residues (see the Methods section for definition). The surface
coverage is defined as 1 − SASAdSASA0 where SASAd and SASA0 refer to the SASA values measured with and
without the DDM detergents respectively. As shown in Fig. 6.14, within 20 ps, the surface coverage in the
SimShape simulation already reached 40%, and it leveled off after 40 ps. The average surface coverage of the
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FIGURE 6.9 Representative detergent orientations in the DDM-GLUT1 proteomicelles from the SimShape GSMD
simulation (top), relaxation simulation (middle), and the benchmark simulation (bottom). Top views are shown
on the left and side views are shown on the right. Some detergents are removed for clarity. GLUT1 protein is shown
in white. DDM detergents heavy atoms are colored by atom type.
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FIGURE 6.10 Distribution of detergent orientations in the SimShape GSMD simulation (SS, gray), relaxation
simulation (SSr, blue), and the benchmark simulation (Benchmark, red).
FIGURE 6.11 Probability distribution of the detergent orientation angles in GLUT1-DDM proteomicelles of dif-
ferent aggregation numbers. Results from the SimShape GSMD simulations (last 20 ps) are shown as thin lines and
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FIGURE 6.12 Distribution of z-coordinates for four DDM atoms from the SimShape GSMD simulation (SS, gray),
relaxation simulation (SSr, blue), and the benchmark simulation (Benchmark, blue).
FIGURE 6.13 Distribution of z coordinates for four DDM atoms (C1, C6, C12, and 1O6) during the SimShape
GSMD simulations of GLUT1-DDM proteomicelles with different aggregation numbers (last 20 ps).
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hydrophobic belt region using the SimShape protocol was 43.7 ± 0.5%, compared to the benchmark value
of 51.1 ± 1.1%. Interestingly, immediately after 10 ps of relaxation MD simulation, the surface coverage
increased to 46.2% (Fig. 6.14 dashed line) and reached an average value of 51.6 ± 0.8% within 10 ns, which is
within the standard deviation of the benchmark. This result means the detergent packing generated by the
SimShape protocol is very close to being optimal. We also measured the surface coverages for proteomicelles
with different aggregation numbers, and all converged to very similar values (Fig. 6.15).


























FIGURE 6.14 Coverage of the GLUT1 hydrophobic surface by DDM detergents during the SimShape GSMD
simulation (SS, left) and the relaxation simulations (SSr, right), with benchmark values (Benchmark) shown in
red. The average values (over the last 20 ps for SS, the last 15 ns for SSr, and the entire trajectory for Benchmark)
are shown as straight lines and the standard deviations are shown as shaded areas. The initial value in the SSr
simulation (after 10 ps) is shown as black dashed line (right). The SASA probe radius was 1.4 Å.
Hydrophobic/hydrophilic contacts
To further investigate the interactions between various components of the systems, we measured the fractions
of contacts between the protein and water or detergent head/tail groups. Due to the lack of explicit solvent
in the SimShape protocol, the fraction of contact between protein and water for the SimShape result was
approximated by the first data point of the relaxation MD simulation (t = 10 ps). The results show that
the contact fraction of GLUT1’s interactions with water in SimShape (10%) was close to the benchmark
value (11 ± 3%) (Fig. 6.16). However, in the SimShape generated proteomicelle, GLUT1 only had contacts
91
FIGURE 6.15 Coverage of the hydrophobic belt surface in GLUT1-DDM micelles with different aggregation num-
bers in the SimShape GSMD simulations (left) and the relaxation simulations (right). The raw data are shown in
translucent colors and running averages shown as solid curves. The average values over the last 15 ns of the relaxation
simulations are shown as straight lines.
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with the detergent tail groups (90%) but not the head groups (0%). In the benchmark simulation, GLUT1
had 83 ± 3% interactions with the detergent tail groups and 6 ± 3% interactions with the detergent head
groups. These differences were much reduced after 5 ns of MD simulation, with average contact fractions
reached 85 ± 2%, 7 ± 2%, and 8 ± 2% for interactions with the detergent tail, head groups, and water,
respectively (Fig. 6.16). For proteomicelles of different detergent aggregation numbers, they all converged
to similar levels of contact fractions, except for the case with 160 DDM detergent molecules. This simulation























FIGURE 6.16 Fraction of contacts (cutoff: 4 Å) between GLUT1 hydrophobic belt residues and the DDM detergents
or water heavy atoms during the relaxation simulations (SSr, blue), with benchmark values (Benchmark) shown in
red. The average values (over the last 15 ns for SSr and the entire trajectory for Benchmark) are shown as straight
lines and the standard deviations are shown as shaded areas. Due to the lack of explicit solvent in the SimShape
GSMD simulation (SS), its contact fraction (gray) was approximated by analyzing the first trajectory frame (after
10 ps) from the SSr simulation.
Residue-level interactions
To identify the specific interactions between detergents and protein residues, we measured the number of
contacts between the protein surface hydrophobic residues (see the Methods section for definition) and the
detergent tail group heavy atoms, as well as between the protein surface hydrophilic surface residues (see
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FIGURE 6.17 Fractions of contacts between GLUT1 hydrophobic residues and detergents (head and tail groups)
or water heavy atoms for proteomicelles of different aggregation numbers during the relaxation simulations. The raw
data is shown in translucent colors and the running averages are shown as solid curves.
the Methods section for definition) and the detergent head group heavy atoms. The hydrophobic contact
number of the SimShape proteomicelle matched that from of the benchmark simulation, although SimShape
produced a slightly lower number of contacts (Fig. 6.18 top) for most residues. Within 30 ns of the
relaxation simulation, the hydrophobic contact improved (Fig. 6.18 top). On the other hand, SimShape
produced much fewer hydrophilic contacts compared to the benchmark (Fig. 6.18 bottom). However, after
further equilibration, the hydrophilic contact improved significantly (Fig. 6.18 bottom). This is more or
less expected since hydrophilic interactions between the DDM head groups and protein hydrophilic residues
are very specific and require more than 100 ps (SimShape time scale) to fully capture. When comparing
the results of the SimShape protocol with different detergent aggregation numbers, the average number of
contacts for each chosen residue were comparable among different proteomicelles (Fig. 6.19). This results
indicates that the grid potential has a strong influence on the final positions of the detergents. Therefore,
the discrepancies between the SimShape results and the benchmark may be reduced by further optimizing
the shape of the grid potential.
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FIGURE 6.18 Contact number between the last carbon atom (C12) from DDM and the surface hydrophobic
residues from GLUT1 (top) as well as between the first oxygen atom (1O6) from DDM head group and the surface
hydrophilic residues from GLUT1 (bottom), for the SimShape GSMD simulation (SS, gray, averaged over the last
20 ps), relaxation simulation (SSr, blue, averaged over the last 15 ns), and the benchmark simulation (Benchmark,
red, averaged over the last 240 ns) using cutoff radius 4 Å.
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FIGURE 6.19 Average number of contacts between GLUT1 hydrophobic residues and the detergent tail heavy
atoms (top) as well as between hydrophilic residues and the detergent head group heavy atoms (bottom) during the
last the 20 ps of the SimShape GSMD simulations of proteomicelles with different aggregation numbers.
Application to other proteins
To explore the necessary changes required for modeling proteomicelles for other proteins, we applied the
SimShape method to a pentameric-ligand gated ion channel from Erwinia chrysanthemi (ELIC) (240), the
multidrug resistance protein P-glycoprotein (Pgp) (241), and the tetrameric water channel aquaporin 1
(AQP1) (242), with 340, 240, and 450 DDM detergents respectively. The detergents aggregation number
was based on the hydrophobic belt surface area of each protein relative to GLUT1. After the proteomicelle
assembly, a 30 ns relaxation MD simulations was performed for each case. All three proteomicelles were
stable during the relaxation MD simulations, and no detergent molecules left the assemblies (Fig. 6.20 and
6.21). For ELIC, a circular torus grid potential was used. After 30 ns, the detergents adopt a pentagon
shape, as seen from the cytoplasmic view (Fig. 6.21 a). For Pgp, an elliptic torus grid potential was used.
After 30 ns of relaxation, the proteomicelle became less elliptic due to the collapsing motion the protein (Fig.
6.21 b). Finally, for AQP1, the grid potential was a circular torus, and the proteomicelle gradually adopted
a square shape after 30 ns of relaxation MD simulation (Fig. 6.21 c). These three cases indicate that the
SimShape method is capable of assembling proteomicelles for proteins of different size and shapes with simple
changes in the geometric parameters of torus-shaped grid potential. These observations also demonstrated
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that detergents can fully adapt to the subtle contour of diverse membrane proteins with the SimShape
method. Note that the results shown here are only for qualitative comparison and the SimShape protocols
for these three proteins were not optimized. Users are advised to explore a different set of parameters in the
SimShape protocol for their own target proteins.
Conclusion
Preparing a proteomicelle is a challenging task. Most current methods rely on geometric placements of deter-
gent molecules (225, 232), with some studies using additional steps of translation and energy minimization
to remove steric clashes (178, 181). In this study, we have demonstrated the effectiveness of the alternative
SimShape method. By design, a customized grid potential is generated for the target protein and a GSMD
stimulation is carried out to assemble the detergents into a target shape defined by the grid potential. No
steric clashes or ring-piercings can occur owing to incorporation of molecular dynamics into the protocol.
SimShape is also very fast. It shortens the micelle aggregation time to less than 60 ps which can usually
be completed within half an hour of wall clock time when running on a cluster or a supercomputer using
NAMD. By comparing against an unbiased self-assembly simulation of the GLUT1-DDM proteomicelle, we
demonstrate that the SimShape method is able to generate a model with comparable qualities in terms of
size, shape, distribution of individual detergent orientations or z coordinates, and hydrophobic surface cover-
age. The current limitation of the method is the lack of specific interactions between detergent head groups
and protein hydrophilic residues at the cytoplasmic and extracellular sides. This is more or less expected
due to the extremely short simulation duration in the SimShape protocol. This issue will be addressed in
the near future by exploring methods for increasing the attraction between these two groups of atoms. The
SimShape method is not meant to replace existing methods, but to provide an alternative approach to model
proteomicelles similar to the ones showcased in this study.
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FIGURE 6.20 Side views of the proteomicelles (with DDM) built for (a) ELIC, (b) Pgp, and (c) AQP1. The
results of the SimShape protocol are shown on the left, and the relaxed states (after 30 ns) are shown on the left.
PDB IDs are shown in parentheses.
98
FIGURE 6.21 Snapshots of the proteomicelles (with DDM) built for (a) ELIC (intracellular-side view), (b) Pgp
(extracellular-side view), and (c) AQP1 (extracellular-side view). The results of the SimShape protocol are shown
on the left, and the relaxed states (after 30 ns) are shown on the left. PDB IDs are shown in parentheses.
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42. Giacomo Fiorin, Michael L. Klein, and Jérôme Hénin. Using collective variables to drive molecular
dynamics simulations. Mol. Phys., 111(22–23):3345–3362, 2013.
43. Alexander D. MacKerell, Jr., Michael Feig, and Charles L. Brooks, III. Extending the treatment of
backbone energetics in protein force fields: Limitations of gas-phase quantum mechanics in reproducing
protein conformational distributions in molecular dynamics simulations. J. Comp. Chem., 25(11):1400–
1415, 2004.
44. Shuichi Miyamoto and Peter A. Kollman. SETTLE: An analytical version of the SHAKE and RATTLE
algorithm for rigid water molecules. J. Comp. Chem., 13(8):952–962, 1992.
45. Tom Darden, Darrin York, and Lee Pedersen. Particle mesh Ewald: An N ·log(N ) method for Ewald
sums in large systems. J. Chem. Phys., 98:10089–10092, 1993.
46. R. Zhou, E. Harder, H. Zu, and B. J. Berne. Efficient multiple time step method for use with ewald
and particle mesh ewald for large biomolecular systems. J. Chem. Phys., 115:2348, 2001.
47. D. Barash, L. Yang, X. Qian, and T. Schlick. Inherent speedup limitations in multiple time step/particle
mesh Ewald algorithms. J. Comp. Chem., 24:77–88, 2003.
48. M. P. Allen and D. J. Tildesley. Computer Simulation of Liquids. Oxford University Press, New York,
1987.
49. Glenn J. Martyna, Douglas J. Tobias, and Michael L. Klein. Constant pressure molecular dynamics
algorithms. J. Chem. Phys., 101:4177–4189, 1994.
50. Scott E. Feller, Yuhong Zhang, and Richard W. Pastor. Constant pressure molecular dynamics simu-
lation: The Langevin piston method. J. Chem. Phys., 103:4613–4621, 1995.
51. R. Fletcher and C. M. Reeves. Function minimization by conjugated gradients. Computer Journal,
7:149–154, 1964.
52. Wenyu Sun and Ya-Xiang Yuan. Optimization theory and methods: nonlinear programming. Springer,
New York, 2006.
53. Philippa Marrack, James P Scott-Browne, Shaodong Dai, Laurent Gapin, and John W Kappler. Evolu-
tionarily conserved amino acids that control TCR-MHC interaction. Annu. Rev. Immunol., 26:171–203,
2008.
54. Yuan-Hua Ding, Brian M Baker, David N Garboczi, William E Biddison, and Don C Wiley. Four
A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical.
Immunity, 11:45–56, 1999.
55. Daniel R Scott, Oleg Y Borbulevych, Kurt H Piepenbrink, Steven A Corcelli, and Brian M Baker.
Disparate degrees of hypervariable loop flexibility control T-cell receptor cross-reactivity, specificity,
and binding mechanism. J. Mol. Biol., 414:385–400, 2011.
56. Susan J Gagnon, Oleg Y Borbulevych, Rebecca L Davis-Harrison, Richard V Turner, Marale Damir-
jian, Alison Wojnarowicz, William E Biddison, and Brian M Baker. T cell receptor recognition via
cooperative conformational plasticity. J. Mol. Biol., 363:228–243, 2006.
57. Cyril F Reboul, Grischa R Meyer, Benjamin T Porebski, Natalie A Borg, and Ashley M Buckle.
Epitope flexibility and dynamic footprint revealed by molecular dynamics of a pMHC-TCR complex.
8:e1002404, 2012.
58. Eric S Huseby, Janice White, Frances Crawford, Tibor Vass, Dean Becker, Clemencia Pinilla, Philippa
Marrack, and John W Kappler. How the T cell repertoire becomes peptide and MHC specific. Cell,
122:247–260, 2005.
103
59. Wan-Lin Lo, Benjamin D Solomon, David L Donermeyer, Chyi-Song Hsieh, and Paul M Allen. T cell
immunodominance is dictated by the positively selecting self-peptide. eLife, 3:e01457, 2014.
60. Alexander C. Jackson and Roger A. Nicoll. The expanding social network of ionotropic glutamate
receptors: TARPs and other transmembrane auxiliary subunits. Neuron, 70:178–199, 2011.
61. Stephen F. Traynelis, Lonnie P. Wollmuth, Chris J. McBain, Frank S. Menniti, Katie M. Vance,
Kevin K. Ogden, Kasper B. Hansen, Hongjie Yuan, Scott J. Myers, and Ray Dingledine. Glutamate
receptor ion channels: Structure, regulation, and function. Pharmacol. Rev., 62:405–496, 2010.
62. Lu Chen, Dane M. Chetkovich, Ronald S. Petralia, Neal T. Sweeney, Yoshimi Kawasaki, Robert J.
Wenthold, David S. Bredt, and Roger A. Nicoll. Stargazin regulates synaptic targeting of AMPA
receptors by two distinct mechanisms. Nature, 408:936–943, 2000.
63. Aaron D. Milstein and Roger A. Nicoll. Regulation of AMPA receptor gating and pharmacology by
TARP auxiliary subunits. Trends Pharmacol. Sci., 29:333–339, 2008.
64. Aaron D Milstein, Wei Zhou, Siavash Karimzadegan, David S Bredt, and Roger A Nicoll. Tarp subtypes
differentially and dose-dependently control synaptic AMPA receptor gating. Neuron, 55:905–918, 2007.
65. Ian D Soto, David Coombs, Leah Kelly, Mark Farrant, and Stuart G Cull-Candy. Stargazin attenuates
intracellular polyamine block of calcium-permeable AMPA receptors. Nature Neurosci., 10:1260–1267,
2007.
66. Hillel Tomita, Susumu Adesnik, Masayuki Sekiguchi, Wei Zhang, Keiji Wada, James R Howe, Roger A
Nicoll, and David S Bredt. Stargazin modulates AMPA receptor gating and trafficking by distinct
domains. Nature, 435:1052–1058, 2005.
67. Z. Galen Wo and Robert E Oswald. Unraveling the modular design of glutamate-gated ion channels.
Trends in Neurosciences, 18:161–168, 1995.
68. Lonnie P Wollmuth and Alexander I Sobolevsky. Structure and gating of the glutamate receptor ion
channel. Trends in Neurosciences, 27:321–328, 2004.
69. Neali Armstrong and Eric Gouaux. Mechanisms for activation and antagonism of an AMPA-sensitive
glutamate receptor: Crystal structures of the GluR2 ligand binding core. Neuron, 28:165–181, 2000.
70. Rongsheng Jin, Satinder K Singh, Shenyan Gu, Hiroyasu Furukawa, Alexander I Sobolevsky, Jie Zhou,
Yan Jin, and Eric Gouaux. Crystal structure and association behaviour of the GluR2 amino-terminal
domain. EMBO J., 28:1812–1823, 2009.
71. Alexander I. Sobolevsky, Michael P. Rosconi, and Eric Gouaux. X-ray structure, symmetry and mech-
anism of an AMPA-subtype glutamate receptor. Nature, 462:745–756, 2009.
72. Yu Sun, Rich Olson, Michelle Horning, Neali Armstrong, Mark Mayer, and Eric Gouaux. Mechanism
of glutamate receptor desensitization. Nature, 417:245–253, 2002.
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188. Gilbert G. Privé. Detergents for the stabilization and crystallization of membrane proteins. Methods,
41:388–397, 2007.
189. Pil Seok Chae, Sø G F Rasmussen, Rohini R Rana, Kamil Gotfryd, Richa Chandra, Michael A Goren,
Andrew C Kruse, Shailika Nurva, Claus J Loland, Yves Pierre, David Drew, Jean-Luc Popot, Daniel
Picot, Brian G Fox, Lan Guan, Ulrik Gether, Bernadette Byrne, Brian Kobilka, and Samuel H Gell-
man. Maltose-neophentyl glyco (mng) amphiphiles for solubilization, stabilization and crystallization
of membrane proteins. Nat. Methods, 7:1003–1008, 2010.
190. Aditya Pandey, Kyungsoo Shin, Robin E. Patterson, Xiang-Qin Liu, and Jan K. Rainey. Current strate-
gies for protein production and purification enabling membrane protein structural biology. Biochem.
Cell Biol., 94:507–527, 2016.
191. Daria Slowik and Richard Henderson. Benchmarking the stability of human detergent-solubilised
voltage-gated channels for structural studies using eel as a reference. Biochim. Biophys. Acta
Biomembr., 1848:1545–1551, 2015.
192. Eamonn Reading, Troy A. Walton, Idlir Liko, Michael T. Marty, Arthur Laganowsky, Douglas C. Rees,
and Carol V. Robinson. The effect of detergent, temperature, and lipid on the oligomeric state of MscL
constructs: insights from mass spectrometry. Chem. Biol., 22:593–603, 2015.
193. Simon Erlendsson, Kamil Gotfryd, Flemming Hofmann Larsen, Jonas Sigurd Mortensen, Michel-
Andreas Geiger, Barth-Jan van Rossum, Hartmut Oschkinat, Ulrik Gether, Kaare Teilum, and Claus J
Loland. Direct assessment of substrate binding to the neurotransmiter:sodium symporter LeuT by solid
state NMR. eLife, 6:e19314, 2017.
111
194. M. Joanne Lemieux, Reinhart A.F. Reithmeier, and Da-Neng Wang. Importance of detergent and
phopholipid in the crystallization of the human erythrocyte anion-exchanger membrane domain.
J. Struct. Biol., 137:322–332, 2002.
195. Erhu Cao, Maofu Liao, Yifan Cheng, and David Julius. TRPV1 structures in distinct conformations
reveal activation mechanisms. Nature, 504:113–118, 2013.
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